<SEC-DOCUMENT>0001104659-20-027550.txt : 20200302
<SEC-HEADER>0001104659-20-027550.hdr.sgml : 20200302
<ACCEPTANCE-DATETIME>20200302090302
ACCESSION NUMBER:		0001104659-20-027550
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20200228
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200302
DATE AS OF CHANGE:		20200302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Marker Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001094038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880277072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37939
		FILM NUMBER:		20674408

	BUSINESS ADDRESS:	
		STREET 1:		3200 SOUTHWEST FREEWAY
		STREET 2:		SUITE 2240
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
		BUSINESS PHONE:		(713) 400-6400

	MAIL ADDRESS:	
		STREET 1:		3200 SOUTHWEST FREEWAY
		STREET 2:		SUITE 2240
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC.
		DATE OF NAME CHANGE:	20170629

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TAPIMMUNE INC
		DATE OF NAME CHANGE:	20070628

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENEMAX CORP
		DATE OF NAME CHANGE:	20020718
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2011380d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, DC 20549</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="border-bottom: Black 1pt solid; border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>FORM 8-K</B></FONT>&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>February 28, 2020&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="border-top: Black 1pt solid; font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MARKER THERAPEUTICS, INC.</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact Name of Registrant as Specified
in Charter)</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: center; width: 24%"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 14%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: center; width: 24%"><FONT STYLE="font-size: 10pt"><B>001-37939</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 14%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: center; width: 24%"><FONT STYLE="font-size: 10pt"><B>45-4497941</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of Incorporation)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;3200 Southwest Freeway, Suite
2240</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Houston, TX 77027</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices,
and Zip Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(713) 400-6400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top; width: 92%"><FONT STYLE="font-size: 10pt">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top; width: 92%"><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top; width: 92%"><FONT STYLE="font-size: 10pt">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Wingdings; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top; width: 92%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-commencement communication pursuant to Rule 13e-4(c) under
        the Exchange Act (17 CFR 240.13e-4(c))</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 39%; border: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Title of each class</FONT></TD>
    <TD STYLE="width: 24%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Trading Symbol(s)</FONT></TD>
    <TD STYLE="width: 37%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">Name of each exchange on which</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">registered</FONT></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Common Stock, Par Value $0.001</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">MRKR</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt">Nasdaq Global Market</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2 of this chapter).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">Emerging growth
company <FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item&nbsp;1.01</B></TD><TD><B>Entry into a Material Definitive Agreement</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Purchase Agreement and Registration Rights Agreement with
Aspire Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 28, 2020,
Marker Therapeutics, Inc. (the &#8220;Company&#8221;), entered into a common stock purchase agreement (the &#8220;Purchase Agreement&#8221;)
with Aspire Capital Fund, LLC, an Illinois limited liability company (&#8220;Aspire Capital&#8221;) which provides that, upon the
terms and subject to the conditions and limitations set forth therein, Aspire Capital is committed to purchase up to an aggregate
of $30.0 million of shares of the Company&#8217;s common stock over the 30-month term of the Purchase Agreement. In consideration
for entering into the Purchase Agreement, concurrently with the execution of the Purchase Agreement, the Company issued to Aspire
Capital 345,357 shares of the Company&#8217;s common stock (the &#8220;Commitment Shares&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently with entering
into the Purchase Agreement, the Company also entered into a registration rights agreement with Aspire Capital (the &#8220;Registration
Rights Agreement&#8221;), in which the Company agreed to file with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
a prospectus supplement to the Company&#8217;s effective shelf registration statement on Form S-3 (File No. 333-232122) registering
all of the shares of common stock that may be offered to Aspire Capital from time to time, including the Commitment Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">Under
the Purchase agreement, on any trading day selected by the Company, the Company has the right, in its sole discretion, to present
Aspire Capital with a purchase notice (each, a &#8220;Purchase Notice&#8221;), directing Aspire Capital (as principal) to purchase
up to 100,000 shares of the Company&#8217;s common stock per business day, up to $30.0 million of the Company&#8217;s common stock
in the aggregate at a per share price (the &#8220;Purchase Price&#8221;) equal to the lesser of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the lowest sale price of the Company&#8217;s common stock on the purchase date; or</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">the arithmetic average of the three (3) lowest closing sale prices
for the Company&#8217;s common stock during the ten (10) consecutive trading days ending on the trading day immediately preceding
the purchase date.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and Aspire
Capital also may mutually agree to increase the number of shares that may be sold to as much as an additional 2,000,000 shares
per business day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on any
date on which the Company submits a Purchase Notice to Aspire Capital in an amount equal to at least 100,000 shares, the Company
also has the right, in its sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each,
a &#8220;VWAP Purchase Notice&#8221;) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate
shares of the Company&#8217;s common stock traded on its principal market on the next trading day (the &#8220;VWAP Purchase Date&#8221;),
subject to a maximum number of shares the Company may determine. The purchase price per share pursuant to such VWAP Purchase Notice
is generally 97% of the volume-weighted average price for the Company&#8217;s common stock traded on its principal market on the
VWAP Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">The
Purchase Price will be adjusted for any reorganization, recapitalization, non-cash dividend, stock split, or other similar transaction
occurring during the period(s) used to compute the Purchase Price. The Company may deliver multiple Purchase Notices and VWAP Purchase
Notices to Aspire Capital from time to time during the term of the Purchase Agreement, so long as the most recent purchase has
been completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">The
Purchase Agreement provides that the Company and Aspire Capital shall not effect any sales under the Purchase Agreement on any
purchase date where the closing sale price of the Company&#8217;s common stock is less than $0.25. There are no trading volume
requirements or restrictions under the Purchase Agreement, and the Company will control the timing and amount of sales of the Company&#8217;s
common stock to Aspire Capital. Aspire Capital has no right to require any sales by the Company, but is obligated to make purchases
from the Company as directed by the Company in accordance with the Purchase Agreement. There are no limitations on use of proceeds,
financial or business covenants, restrictions on future fundings, rights of first refusal, participation rights, penalties or liquidated
damages in the Purchase Agreement. The Purchase Agreement may be terminated by the Company at any time, at its discretion, without
any cost to the Company. Aspire Capital has agreed that neither it nor any of its agents, representatives and affiliates shall
engage in any direct or indirect short-selling or hedging of the Company&#8217;s common stock during any time prior to the termination
of the Purchase Agreement. Any proceeds from the Company receives under the Purchase Agreement are expected to be used for working
capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">The Purchase Agreement
provides that the number of shares that may be sold pursuant to the Purchase Agreement will be limited to 9,232,814 shares, including
the Commitment Shares, or the Exchange Cap, which represents 19.99% of the Company&#8217;s outstanding shares of Common Stock as
of February 28, 2020, unless stockholder approval is obtained to issue more than 19.99%. This limitation will not apply if, at
any time the Exchange Cap is reached and at all times thereafter, the average price paid for all shares issued under the Purchase
Agreement is equal to or greater than $2.41, which was the Closing Sale Price immediately preceding the execution of the Purchase
Agreement. The Company is not required or permitted to issue any shares of Common Stock under the Purchase Agreement if such issuance
would breach its obligations under the rules or regulations of The Nasdaq Global Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing is a
summary description of certain terms of the Purchase Agreement and the Registration Rights Agreement and, by its nature, is incomplete.
Copies of the Purchase Agreement and Registration Rights Agreement are filed herewith as Exhibits 10.1 and 4.1, respectively, to
this Current Report on Form 8-K and are incorporated herein by reference. All readers are encouraged to read the entire text of
the Purchase Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is filing
the opinion of its counsel, Cooley LLP, relating to the legality of the shares of common stock offered and sold pursuant to the
Purchase Agreement, as Exhibit 5.1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 7.01</B></TD><TD><B>Regulation FD Disclosure.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 2, 2020, the
Company issued a press release announcing that it has entered into the Purchase Agreement with Aspire Capital. A copy of the press
release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in
this Item 7.01 of this Current Report on 8-K (including Exhibit 99.1) is furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or
Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall not be deemed incorporated by reference
into any other filing with the Securities and Exchange Commission made by the Company, whether made before or after today&#8217;s
date, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references
in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD STYLE="text-align: left"><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>(d) Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Exhibit<BR>
 Number</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Description</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 8%; font-size: 10pt; text-align: center"><A HREF="tm2011380d1_ex4-1.htm" STYLE="-sec-extract: exhibit">4.1</A></TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 90%; font-size: 10pt; text-align: left"><A HREF="tm2011380d1_ex4-1.htm" STYLE="-sec-extract: exhibit">Registration Rights Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><A HREF="tm2011380d1_ex5-1.htm" STYLE="-sec-extract: exhibit">5.1</A></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="tm2011380d1_ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Cooley LLP</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><A HREF="tm2011380d1_ex10-1.htm" STYLE="-sec-extract: exhibit">10.1</A></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="tm2011380d1_ex10-1.htm" STYLE="-sec-extract: exhibit">Common Stock Purchase Agreement, dated February 28, 2020, between Marker Therapeutics, Inc. and Aspire Capital Fund, LLC</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><A HREF="tm2011380d1_ex5-1.htm" STYLE="-sec-extract: exhibit">23.1</A></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="tm2011380d1_ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of Cooley LLP (included in Exhibit 5.1)</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><A HREF="tm2011380d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="tm2011380d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release dated March 2, 2020, titled &ldquo;Marker Therapeutics, Inc. Announces $30.0 Million Common Stock Purchase Agreement.&rdquo;</A></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Signatures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt"><FONT STYLE="font-size: 10pt"><B>MARKER THERAPEUTICS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 3pt">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 3pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%; padding-right: 3pt"><FONT STYLE="font-size: 10pt">/s/ Anthony Kim</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt"><FONT STYLE="font-size: 10pt">Anthony Kim</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD STYLE="padding-right: 3pt"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3pt"><FONT STYLE="font-size: 10pt">Dated: March 2, 2020</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 3pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>tm2011380d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B><U>Execution
Copy</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of February&nbsp;28, 2020, by and between <B>MARKER
THERAPEUTICS,&nbsp;INC., </B>a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>ASPIRE CAPITAL FUND, LLC,</B> an
Illinois limited liability company (together with its permitted assigns, the &ldquo;<B>Buyer</B>&rdquo;). Capitalized terms used
herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by
and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time
to time, the &ldquo;<B>Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
the terms and subject to the conditions of the Purchase Agreement, (i)&nbsp;the Company has agreed to issue to the Buyer, and the
Buyer has agreed to purchase, up to Thirty Million Dollars ($30,000,000) of the Company&rsquo;s common stock, par value $0.001
per share (the &ldquo;<B>Common Stock</B></FONT>&rdquo;), pursuant to Section&nbsp;1 of the Purchase Agreement (such shares, the
 &ldquo;<B>Purchase Shares</B>&rdquo;), and (ii)&nbsp;the Company has agreed to issue to the Buyer such number of shares of Common
Stock as is required pursuant to Section&nbsp;4(e)&nbsp;of the Purchase Agreement (the <B>&ldquo;Commitment Shares&rdquo;</B>);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
induce the Buyer to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the
Securities Act of 1933, as amended, and the rules&nbsp;and regulations thereunder, or any similar successor statute (collectively,
the &ldquo;<B>1933 Act</B>&rdquo;), and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>NOW,
THEREFORE,</B></FONT> in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DEFINITIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">As used in this Agreement,
the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Person</B>&rdquo;
means any person or entity including any corporation, a limited liability company, an association, a partnership, an organization,
a business, an individual, a governmental or political subdivision thereof or a governmental agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT><B>&ldquo;Prospectus&rdquo;
</B>means the base prospectus, including all documents incorporated therein by reference, included in any Registration Statement</FONT></FONT>
<FONT>(as hereinafter defined), as it may be supplemented by a prospectus or the Prospectus Supplement
(as hereinafter defined), in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the
Company with the </FONT>U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) <FONT>pursuant
to Rule&nbsp;424(b)&nbsp;under the 1933 Act, together with any then issued &ldquo;issuer free writing prospectus(es),&rdquo; as
defined in Rule&nbsp;433 of the 1933 Act, relating to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Register</B>,&rdquo;
 &ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected by preparing and filing
one or more registration statements of the Company under the 1933 Act and pursuant to Rule&nbsp;415 under the 1933 Act or any successor
rule&nbsp;providing for offering securities on a continuous basis (&ldquo;<B>Rule&nbsp;415</B>&rdquo;), and the declaration or
ordering of effectiveness of such registration statement(s)&nbsp;by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Registrable
Securities</B>&rdquo; means the Purchase Shares <FONT>that</FONT> may from time to time be issued
or issuable to the Buyer upon purchases of the Available Amount under the Purchase Agreement (without regard to any limitation
or restriction on purchases), the Commitment Shares issued or issuable to the Buyer, and any shares of capital stock issued or
issuable with respect to the Purchase Shares, the Commitment Shares or the Purchase Agreement as a result of any stock split, stock
dividend, recapitalization, exchange or similar event, without regard to any limitation on purchases under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Registration
Statement</B>&rdquo; means the Shelf Registration Statement and any other registration statement of the Company<FONT>,
as amended when it became effective, including all documents filed as part thereof or incorporated by reference therein, and including
any information contained in a Prospectus subsequently filed with the SEC pursuant to Rule&nbsp;424(b)&nbsp;under the 1933 Act
or deemed to be a part of such registration statement pursuant to Rule&nbsp;430B or 462(b)&nbsp;of the 1933 Act,</FONT> covering
</FONT>only the sale of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">f.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Shelf
Registration Statement</B>&rdquo; means the Company&rsquo;s existing registration statement on Form&nbsp;S-3 (File No.&nbsp;333-232122).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REGISTRATION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Mandatory
Registration</U>. The Company shall within two (2)&nbsp;Business </FONT>Days from the Commencement Date file with the SEC a prospectus
supplement to the <FONT>Shelf</FONT> Registration Statement <FONT>specifically
relating to the Registrable Securities (the &ldquo;<B>Prospectus Supplement</B>&rdquo;). </FONT> The Buyer and its counsel shall
have had a reasonable opportunity to review and comment upon such <FONT>Prospectus Supplement</FONT>
prior to its filing with the SEC. The Buyer shall furnish all information reasonably requested by the Company for inclusion therein.
The Company shall use its reasonable best efforts to keep the Shelf Registration Statement effective pursuant to Rule&nbsp;415
promulgated under the 1933 Act and available for sales of all of the Registrable Securities at all times until the earlier of (i)&nbsp;the
Company no longer qualifies to make sales under the Shelf Registration Statement (which shall be understood to include the inability
of the Company to immediately register sales of Registrable Securities to the Buyer under the Shelf Registration Statement or any
New Registration Statement (as defined below) pursuant to General Instruction I.B.6 of Form&nbsp;S-3), (ii)&nbsp;the date on which
the Company shall have sold all the Registrable Securities and no Available Amount remains under the Purchase Agreement, or (iii)&nbsp;the
date on which the Purchase Agreement is terminated (the &ldquo;<B>Registration Period</B>&rdquo;). The Shelf Registration Statement
(including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule&nbsp;424
Prospectus</U>. The Company shall, to the extent required by applicable securities regulations, from time to time file with the
SEC, pursuant to Rule&nbsp;424 promulgated under the 1933 Act, a prospectus, including any amendments or prospectus supplements
thereto, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Buyer and its
counsel shall have </FONT>two (2)&nbsp;Business Days to review and comment upon such prospectus prior to its filing with the SEC.
The Buyer shall use its reasonable best efforts to comment upon such prospectus within two (2)&nbsp;Business Days from the date
the Buyer receives the final version of such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sufficient
Number of Shares Registered</U>. In the event the number of shares available under the Shelf Registration Statement is insufficient
to cover the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Shelf Registration Statement
or file a new registration statement (a &ldquo;<B>New Registration Statement</B>&rdquo;), so as to cover all of such Registrable
Securities as soon as reasonably practicable, but in any event not later than ten (10)&nbsp;Business Days after the necessity therefor
arises. The Company shall use its reasonable best efforts to have such amendment and/or New Registration Statement become effective
as soon as reasonably practicable following the filing thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RELATED
OBLIGATIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">With
respect to the Registration Statement and whenever any Registrable Securities are to be registered pursuant to Sections 2(a)&nbsp;and
(c), including on the Shelf Registration Statement or on any New Registration Statement, the Company shall use its reasonable</FONT>
best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof
and, pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any Registration
Statement and any New Registration Statement and any Prospectus used in connection with such Registration Statement, as may be
necessary to keep the Registration Statement or any New Registration Statement effective at all times during the Registration Period,
subject to Permitted Delays and Section&nbsp;3(e)&nbsp;hereof and, during such period, comply with the provisions of the 1933 Act
with respect to the disposition of all Registrable Securities of the Company covered by the Registration Statement or any New Registration
Statement until such </FONT>time as all of such Registrable Securities shall have been disposed of in accordance with the intended
methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. Should the Company file a
post-effective amendment to the Registration Statement or a New Registration Statement, the Company will use its reasonable best
efforts to have such filing declared effective by the SEC within thirty (30) consecutive Business Days following the date of filing<FONT>,
which such period shall be extended for an additional </FONT>thirty (30) Business Days if the Company receives a comment letter
from the SEC in connection therewith. If (i)&nbsp;there is material non-public information regarding the Company which the Company&rsquo;s
Board of Directors reasonably determines not to be in the Company&rsquo;s best interest to disclose and which the Company is not
otherwise required to disclose or (ii)&nbsp;there is a significant business opportunity (including, but not limited to, the acquisition
or disposition of assets (other than in the ordinary course of business) or any merger, consolidation, tender offer or other similar
transaction) available to the Company which the Company&rsquo;s Board of Directors reasonably determines not to be in the Company&rsquo;s
best interest to disclose and which the Company would be required to disclose under a Registration Statement or a New Registration
Statement, then the Company may postpone or suspend filing or effectiveness of such Registration Statement or New Registration
Statement or use of the prospectus under the Registration Statement or New Registration Statement for a period not to exceed thirty
(30) consecutive days, provided that the Company may not postpone or suspend its obligation under this Section&nbsp;3(a)&nbsp;for
more than sixty (60) days in the aggregate during any twelve (12) month period (each, a &ldquo;<B>Permitted Delay</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall submit to the Buyer for review and comment any disclosure in the Registration Statement, and all amendments and supplements
thereto (other than prospectus supplements that consist only of a copy of a filed Form&nbsp;10-K, Form&nbsp;10-Q or Current Report
on Form&nbsp;8-K or any amendment as a result of the Company&rsquo;s filing of a document that is incorporated by reference into
the Registration Statement), containing information provided by the Buyer for inclusion in such document and any descriptions or
disclosure regarding the Buyer, the Purchase Agreement, including the transaction contemplated thereby, or this Agreement at least
two (2)&nbsp;Business Days prior to their filing with the SEC, and not file any document in a form to which Buyer reasonably and
timely objects. Upon request of the Buyer, the Company shall provide to the Buyer all disclosure in the Registration Statement
and all amendments and supplements thereto (other than prospectus supplements that consist only of a copy of a filed Form&nbsp;10-K,
Form&nbsp;10-Q or Current Report on Form&nbsp;8-K or any amendment as a result of the Company&rsquo;s filing of a document that
is incorporated by reference into a Registration Statement) at least two (2)&nbsp;Business </FONT>Days prior to their filing with
the SEC, and not file any document in a form to which Buyer reasonably and timely objects. The Buyer shall use its reasonable <FONT>best</FONT>
efforts to comment upon the Registration Statement or any New Registration Statement and any amendments or supplements thereto
within two (2)&nbsp;Business Days from the date the Buyer receives the final version thereof. The Company shall furnish to the
Buyer, without charge, any correspondence from the SEC or the staff of the SEC to the Company or its representatives relating to
the Registration Statement or any New Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon
request of the Buyer, the Company shall furnish to the Buyer, (i)&nbsp;promptly after the same is prepared and filed with the SEC,
at least one copy of the Registration Statement and any amendment(s)&nbsp;thereto, including all financial statements and schedules,
all documents incorporated therein by reference and all exhibits, (ii)&nbsp;upon the effectiveness of any amendment(s)&nbsp;to
a Registration Statement, a copy of the prospectus included in such Registration Statement and all amendments and supplements thereto
(or such other number of copies as the Buyer may reasonably request) and (iii)&nbsp;such other documents, including copies of any
preliminary or final prospectus, as the Buyer may reasonably request from time to time in order to facilitate the disposition of
the Registrable Securities owned by the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use reasonable</FONT> best efforts to (i)&nbsp;register and qualify, unless an exemption from registration and qualification
is available, the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;blue sky&rdquo;
laws of such jurisdictions in the United States as the Buyer reasonably requests, (ii)&nbsp;subject to Permitted Delays, prepare
and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and
qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii)&nbsp;take such other
actions as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period,
and (iv)&nbsp;take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions;
provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x)&nbsp;qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section&nbsp;3(d), (y)&nbsp;subject
itself to general taxation in any such jurisdiction, or (z)&nbsp;file a general consent to service of process in any such jurisdiction.
The Company shall promptly notify the Buyer who holds Registrable Securities of the receipt by the Company of any notification
with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale under the securities
or &ldquo;blue sky&rdquo; laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat
of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to Permitted Delays, as promptly as reasonably practicable after becoming aware of such event or facts, the Company shall notify
the Buyer in writing if the Company has determined that the Prospectus included in any Registration Statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not misleading, and as promptly as reasonably
practical (taking into account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders
of premature disclosure of such event or facts) prepare a prospectus supplement or amendment to such Registration Statement to
correct such untrue statement or omission, and, upon the Buyer&rsquo;s request, deliver a copy of such prospectus supplement or
amendment to the Buyer. In providing this notice to the Buyer, the Company shall not include any other information about the facts
underlying the Company&rsquo;s determination and shall not in any way communicate any material nonpublic information about the
Company or the Common Stock to the Buyer. The Company shall also promptly notify the Buyer in writing (i)&nbsp;when a prospectus
or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement or any post-effective
amendment has become effective (notification of such effectiveness shall be delivered to the Buyer by facsimile or e-mail on the
same day of such effectiveness), (ii)&nbsp;of any request by the SEC for amendments or supplements to any Registration Statement
or related prospectus or related information, and (iii)&nbsp;of the Company&rsquo;s reasonable determination that a post-effective
amendment to a Registration Statement would be appropriate. In no event shall the delivery of a notice under this Section&nbsp;3(e),
or the resulting unavailability of a Registration Statement, without regard to its duration, for disposition of securities by Buyer
be considered a breach by the Company of its obligations under this Agreement. The preceding sentence in this Section&nbsp;3(e)&nbsp;does
not limit whether an event of default has occurred as set forth in Section&nbsp;9(a)&nbsp;of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">f.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use its reasonable</FONT> best efforts to prevent the issuance of any stop order or other suspension of effectiveness
of any Registration Statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction
and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest practical time
and to notify the Buyer of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation
or threat of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">g.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall (i)&nbsp;cause all the Registrable Securities to be listed on each securities exchange on which securities of the
same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules&nbsp;of such exchange, or (ii)&nbsp;secure designation and quotation of all the Registrable Securities if the Principal
Market (as such term is defined in the Purchase Agreement) is an automated quotation system. The Company shall pay all fees and
expenses in connection with satisfying its obligation under this Section.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">h.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall cooperate with the Buyer to facilitate the timely preparation and delivery of certificates or book-entry forms (not
bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to any Registration Statement and
enable such certificates or book-entry forms to be in such denominations or amounts as the Buyer may reasonably request and registered
in such names as the Buyer may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall at all times provide a transfer agent and registrar with respect to its Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">j.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
reasonably requested by the Buyer, the Company shall (i)&nbsp;promptly incorporate in a prospectus supplement or post-effective
amendment to the Registration Statement such information as the Buyer believes should be included therein relating to the sale
and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable
Securities being sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities;
(ii)&nbsp;make all required filings of such prospectus supplement or post-effective amendment as promptly as practicable once notified
of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii)&nbsp;supplement or make
amendments to any Registration Statement (including by means of any document incorporated therein by reference).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">k.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall use its reasonable</FONT> best efforts to cause the Registrable Securities covered by any Registration Statement
to be registered with or approved by such other governmental agencies or authorities in the United States as may be necessary to
consummate the disposition of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">l.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
reasonably requested by the Buyer <FONT>at any time</FONT>, the Company shall deliver to the Buyer
a written confirmation of whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason
(including, without limitation, the issuance of a stop order) and whether or not the Registration Statement is currently effective
and available to the Company for sale of all of the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">m.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to take all other reasonable actions as necessary and reasonably requested by the Buyer to expedite and facilitate
disposition by the Buyer of Registrable Securities pursuant to any Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OBLIGATIONS
OF THE BUYER.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer has furnished to the Company in <U>Exhibit&nbsp;<FONT>A</FONT></U> hereto such information
regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held
by it as required to effect the registration of such Registrable Securities and shall execute such documents in connection with
such registration as the Company may reasonably request. The Company shall notify the Buyer in writing of any other information
the Company reasonably requires from the Buyer in connection with any Registration Statement hereunder</FONT>, and the Buyer shall
promptly furnish such information to the Company. The Buyer will as promptly as practicable notify the Company of any material
change in the information set forth in <U>Exhibit&nbsp;<FONT>A</FONT></U>, other than changes in
its ownership of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing
of any amendments and supplements to any Registration Statement hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXPENSES
OF REGISTRATION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">All
reasonable expenses of the Company, other than sales or brokerage commissions</FONT> and fees and disbursements of counsel for
the Buyer, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel
for the Company, shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;INDEMNIFICATION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Buyer, each Person,
if any, who controls the Buyer, the members, the directors, officers, partners, employees, agents, representatives of the Buyer
and each Person, if any, who controls the Buyer within the meaning of the 1933 Act or the Securities Exchange Act of 1934, as amended
(the &ldquo;<B>1934 Act</B>&rdquo;) (each, an &ldquo;<B>Indemnified Person</B>&rdquo;), against any third party losses, claims,
damages, liabilities, judgments, fines, penalties, charges, costs, reasonable and documented attorneys&rsquo; fees, amounts paid
in settlement (with the prior consent of the Company, such consent not to be unreasonably withheld) or reasonable expenses, (collectively,
 &ldquo;<B>Claims</B>&rdquo;) reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding,
investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency
or body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (&ldquo;<B>Indemnified
Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced
or threatened, in respect thereof) arise out of or are based upon: (i)&nbsp;any untrue statement or alleged untrue statement of
a material fact in the Registration Statement, any New Registration Statement or any post-effective amendment thereto or in any
filing made in connection with the qualification of the offering under the securities or other &ldquo;blue sky&rdquo; laws of any
jurisdiction in which Registrable Securities are offered (&ldquo;<B>Blue Sky Filing</B>&rdquo;), or the omission or alleged omission
to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)&nbsp;any
untrue statement or alleged untrue statement of a material fact contained in the final Prospectus or the omission or alleged omission
to state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the
statements therein were made, not misleading, or (iii)&nbsp;any violation or alleged violation by the Company of the 1933 Act,
the 1934 Act, any other law, including, without limitation, any state securities law, or any rule&nbsp;or regulation thereunder
relating to the offer or sale of the Registrable Securities pursuant to the Registration Statement or any New Registration Statement
(the matters in the foregoing clauses (i)&nbsp;through (iii)&nbsp;being, collectively, &ldquo;<B>Violations</B>&rdquo;). The Company
shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for any reasonable and
documented legal fees or other reasonable and documented expenses incurred by them in connection with investigating or defending
any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section&nbsp;6(a):
(A)&nbsp;shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance
upon and in conformity with information furnished in writing to the Company by the Buyer or such Indemnified Person expressly for
use in connection with the preparation of the Registration Statement, any New Registration Statement, the Prospectus or any such
amendment thereof or supplement thereto, if such prospectus was timely made available by the Company; (B)&nbsp;with respect to
any superseded prospectus, shall not inure to the benefit of any such person from whom the person asserting any such Claim purchased
the Registrable Securities that are the subject thereof (or to the benefit of any other Indemnified Person) if the untrue statement
or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or
supplemented, if such revised prospectus was timely made available by the Company pursuant to Section&nbsp;3(c)&nbsp;or Section&nbsp;3(e),
and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to
a violation; (C)&nbsp;shall not be available to the extent such Claim is based on a failure of the Buyer to deliver, or to cause
to be delivered, the prospectus made available by the Company, if such prospectus was theretofore made available by the Company
pursuant to Section&nbsp;3(c)&nbsp;or Section&nbsp;3(e); and (D)&nbsp;shall not apply to amounts paid in settlement of any Claim
if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld.
Such indemnity shall remain in full force and effect </FONT>regardless of any investigation made by or on behalf of the Indemnified
Person and shall survive the transfer of the Registrable Securities by the Buyer pursuant to Section&nbsp;8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with the Registration Statement, any New Registration Statement or Prospectus, the Buyer agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in Section&nbsp;6(a), the Company, each of its directors,
each of its officers who signed the Shelf Registration Statement or signs any New Registration Statement, each Person, if any,
who controls the Company within the meaning of the 1933 Act or the 1934 Act (collectively and together with an Indemnified Person,
an &ldquo;<B>Indemnified Party</B>&rdquo;), against any Claim or Indemnified Damages to which any of them may become subject, under
the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation,
in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with written
information about the Buyer set forth on <U>Exhibit&nbsp;<FONT>A</FONT></U> attached hereto or updated
from time to time in writing by the Buyer and furnished to the Company by the Buyer expressly for <FONT>inclusion
in the Shelf Registration Statement or Prospectus</FONT> or any New Registration Statement or from the failure of the Buyer to
deliver or to cause to be delivered the prospectus made available by the Company, if such prospectus was timely made available
by the Company pursuant to Section&nbsp;3(c)&nbsp;or Section&nbsp;3(e); and, subject to Section&nbsp;6(d), the Buyer will reimburse
any legal or other expenses reasonably incurred by them in connection with investigating or defending any such Claim; provided,
however, that the indemnity agreement contained in this Section&nbsp;6(b)&nbsp;and the agreement with respect to contribution contained
in Section&nbsp;7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written
consent of the Buyer, which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect and
shall survive the transfer of the Registrable Securities by the Buyer pursuant to Section&nbsp;8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section&nbsp;6 of notice of the commencement of any action
or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party
shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section&nbsp;6, deliver to the indemnifying
party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to
the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of
the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified
Party, as the case may be, and upon such notice, the indemnifying party shall not be liable to the Indemnified Person or Indemnified
Party for any legal or other expenses subsequently incurred by the Indemnified Person or Indemnified Party in connection with the
defense thereof; provided, however, that an Indemnified Person or Indemnified Party (together with all other Indemnified Persons
and Indemnified Parties that may be represented without conflict by one counsel) shall have the right to retain its own counsel
with the fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying
party, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate
due to actual or potential differing interests between such Indemnified Person or Indemnified Party and any other party represented
by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in
connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying
party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim.
The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised as to the status of the defense or
any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action, claim
or proceeding effected without its written consent, provided, however, that the indemnifying party shall not unreasonably withhold,
delay or condition its consent. No indemnifying party shall, without the consent of the Indemnified Party or Indemnified Person,
consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person of a release from all liability
in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated
to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating
to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a
reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified
Person or Indemnified Party under this Section&nbsp;6, except to the extent that the indemnifying party is prejudiced in its ability
to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
indemnification required by this Section&nbsp;6 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred.</FONT> Any person receiving a payment
pursuant to this Section&nbsp;6 which person is later determined to not be entitled to such payment shall return such payment (including
reimbursement of expenses) to the person making it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
indemnity agreements contained herein shall be in addition to (i)&nbsp;any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii)&nbsp;any liabilities the indemnifying party may
be subject to pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONTRIBUTION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section&nbsp;6 to the fullest extent permitted by law; provided, however,
that: (i)&nbsp;no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of
the 1933 Act) shall be entitled to contribution from any party who was not guilty of fraudulent misrepresentation; and (ii)&nbsp;contribution
by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received by such seller from the
sale of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ASSIGNMENT
OF REGISTRATION RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Company shall not
assign this Agreement or any rights or obligations hereunder without the prior written consent of the Buyer; provided, however,
that any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company
remains the surviving entity immediately after such transaction shall not be deemed an assignment. The Buyer may not assign its
rights under this Agreement without the prior written consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDMENT
OF REGISTRATION RIGHTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively) only with the written consent of the Company and the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MISCELLANEOUS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered: (i)&nbsp;upon receipt, when delivered personally; (ii)&nbsp;upon receipt,
when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the
sending party); (iii)&nbsp;upon receipt, when sent by electronic message (provided the recipient responds to the message and confirmation
of both electronic messages are kept on file by the sending party); or (iv)&nbsp;one (1)&nbsp;Business Day after timely deposit
with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 94%; margin-left: 0.5in; margin-right: 0.5in">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">If to the Company:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Marker Therapeutics,Inc.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">3200 Southwest Freeway, Suite
    2240</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Houston, TX 77027</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; width: 10%">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; width: 40%">713-400-6400</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Facsimile:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Attention:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Email:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">With a copy (which shall not constitute notice) to:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Cooley LLP</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">55 Hudson Yards</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">New York, NY 10001Telephone:212-479-6474</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">212-479-6275</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Divakar Gupta</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">dgupta@cooley.com</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">If to the Buyer:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Aspire Capital Fund, LLC</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">155 North Wacker Drive, Suite
    1600</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Chicago,IL 60606</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">312-658-0400</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">312-658-4005</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Steven G. Martin</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">smartin@aspirecapital.com</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 94%; margin-left: 0.5in; margin-right: 0.5in">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">With a copy (which shall not constitute notice) to:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Morrison&amp; Foerster LLP</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">2000 Pennsylvania Avenue, NW, Suite
    6000</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Washington, DC 20006</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in; width: 10%">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; width: 40%">202-778-1611</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">202-887-0763</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Martin P. Dunn,Esq.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.375in">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">mdunn@mofo.com</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">or at such
other address and/or facsimile number and/or to the attention of such other person as the recipient party has specified by written
notice given to each other party at least one (1)&nbsp;Business Day prior to the effectiveness of such change. Written confirmation
of receipt (A)&nbsp;given by the recipient of such notice, consent, waiver or other communication, (B)&nbsp;mechanically or electronically
generated by the sender&rsquo;s facsimile machine containing the time, date, and recipient facsimile number, (C)&nbsp;electronically
generated by the sender&rsquo;s electronic mail containing the time, date and recipient email address or (D)&nbsp;provided by a
nationally recognized overnight delivery service, shall be rebuttable evidence of receipt in accordance with clause (i), (ii),
(iii)&nbsp;or (iv)&nbsp;above, respectively.</FONT> Any party to this Agreement may give any notice or other communication hereunder
using any other means (including messenger service, ordinary mail or electronic mail), but no such notice or other communication
shall be deemed to have been duly given unless it actually is received by the party for whom it is intended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
failure or delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power
or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
<FONT>corporate </FONT>laws of the State of Delaware shall govern all issues concerning the relative
rights of the Company and its stockholders. All other questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of Illinois, without giving effect to any choice of law or
conflict of law provision or rule&nbsp;(whether of the State of Illinois or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Illinois. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of Chicago for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this
Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction.
<B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement<B>,</B> the Purchase Agreement and the other Transaction Documents constitute the entire understanding among the parties
hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings,
other than those set forth or referred to herein and therein. This Agreement<B>,</B> the Purchase Agreement and the other Transaction
Documents supersede all other prior oral or written agreements between the Buyer, the Company, their affiliates and persons acting
on their behalf with respect to the subject matter hereof and thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the requirements of Section&nbsp;8, this Agreement shall inure to the benefit of and be binding upon the permitted successors
and assigns of each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">f.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">g.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile
or pdf (or other electronic reproduction of a) signature shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction
of a) signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">h.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver
all such other agreements, certificates, instruments and documents as the other party may reasonably request in order to carry
out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules&nbsp;of
strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">j.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>* * * * * *</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the parties have caused this Registration Rights Agreement to be duly executed as of day and year first above
written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"></TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>THE COMPANY</U></B></FONT><B>:</B></TD>
</TR>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><B>MARKER THERAPEUTICS,&nbsp;INC.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 5%">By:</TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 45%">/s/ Peter Hoang</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Name:</TD>
                                        <TD STYLE="text-align: justify">  Peter Hoang</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Title:</TD>
                                        <TD STYLE="text-align: justify"> President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD COLSPAN="2" STYLE="text-align: justify"><B><U>BUYER:</U></B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD COLSPAN="2" STYLE="text-align: justify"><B>ASPIRE CAPITAL FUND, LLC</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD COLSPAN="2" STYLE="text-align: justify"><B>BY: ASPIRE CAPITAL PARTNERS, LLC</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><B>BY: SGM HOLDINGS
CORP.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">By:</TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Steven G. Martin</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Name:</TD>
                                        <TD STYLE="text-align: justify">Steven G. Martin</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Title:</TD>
                                        <TD STYLE="text-align: justify">President</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Information About The Buyer Furnished
To The Company By The Buyer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Expressly For Use In Connection With
The Registration Statement and Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aspire Capital Partners LLC (&ldquo;Aspire
Partners&rdquo;) is the Managing Member of Aspire Capital Fund, LLC (&ldquo;Aspire Fund&rdquo;). SGM Holdings Corp (&ldquo;SGM&rdquo;)
is the Managing Member of Aspire Partners. Mr.&nbsp;Steven G. Martin (&ldquo;Mr.&nbsp;Martin&rdquo;) is the president and sole
shareholder of SGM, as well as a principal of Aspire Partners. Mr.&nbsp;Erik J. Brown (&ldquo;Mr.&nbsp;Brown&rdquo;) is the president
and sole shareholder of Red Cedar Capital Corp (&ldquo;Red Cedar&rdquo;), which is a principal of Aspire Partners. Mr.&nbsp;Christos
Komissopoulos (&ldquo;Mr.&nbsp;Komissopoulos&rdquo;) is president and sole shareholder of Chrisko Investors Inc. (&ldquo;Chrisko&rdquo;),
which is a principal of Aspire Partners. Mr.&nbsp;William F. Blank,&nbsp;III (&ldquo;Mr.&nbsp;Blank&rdquo;) is president and sole
shareholder of WML Ventures Corp. (&ldquo;WML Ventures&rdquo;), which is a principal of Aspire Partners. Each of Aspire Partners,
SGM, Red Cedar, Chrisko, WML Ventures, Mr.&nbsp;Martin, Mr.&nbsp;Brown, Mr.&nbsp;Komissopoulos and Mr.&nbsp;Blank may be deemed
to be a beneficial owner of common stock held by Aspire Fund. Each of Aspire Partners, SGM, Red Cedar, Chrisko, WML Ventures, Mr.&nbsp;Martin,
Mr.&nbsp;Brown, Mr.&nbsp;Komissopoulos and Mr.&nbsp;Blank disclaims beneficial ownership of the common stock held by Aspire Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm2011380d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2011380d1_ex5-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Divakar Gupta</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">+1 212 479 6474</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">dgupta@cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 2, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marker Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3200 Southwest Freeway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suite 2240</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Houston, TX 77027</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You have requested our opinion with respect
to certain matters in connection with the offer and sale by Marker Therapeutics, Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;),
of 345,357 shares (the &ldquo;<B><I>Commitment Shares</I></B>&rdquo;) of the Company&rsquo;s common stock, par value $0.001 per
share (&ldquo;<B><I>Common Stock</I></B>&rdquo;), and additional shares of Common Stock having aggregate sale proceeds of up to
$30 million (together with the Commitment Shares, the &ldquo;<B><I>Shares</I></B>&rdquo;), pursuant to a Registration Statement
on Form S-3 (No.&nbsp;333&#45;232122) (the <I>&ldquo;<B>Registration Statement</B>&rdquo;</I>) filed with the Securities and Exchange
Commission (the <I>&ldquo;<B>Commission</B>&rdquo;</I>) under the Securities Act of 1933, as amended (the &ldquo;<B><I>Act</I></B><I>&rdquo;</I>),
the related prospectus included within the Registration Statement (the &ldquo;<B><I>Base Prospectus</I></B>&rdquo;), and the prospectus
supplement to be filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations of the Act (together with the Base
Prospectus, the &ldquo;<B><I>Prospectus</I></B>&rdquo;). The Shares are to be sold by the Company pursuant to that certain Common
Stock Purchase Agreement, dated as of February 28, 2020 (the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;), by and between the
Company and Aspire Capital Fund, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this opinion, we have
examined and relied upon (a) the Registration Statement and the Prospectus, (b) the Company&rsquo;s Certificate of Incorporation,
and Bylaws, each as currently in effect, and (c) originals or copies certified to our satisfaction, of such records, documents,
certificates, opinions, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render
the opinion expressed below. We have assumed the genuineness and authenticity of all documents submitted to us as originals and
the conformity to originals of all documents submitted to us as copies thereof; the accuracy, completeness and authenticity of
certificates of public officials and the due authorization, execution and delivery of all documents by all persons other than the
Company where due execution and delivery are a prerequisite to the effectiveness thereof. As to certain factual matters, we have
relied upon a certificate of an officer of the Company and have not sought independently to verify such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have assumed (i) that each sale of Shares
will be duly authorized by the Board of Directors of the Company, a duly authorized committee thereof or a person or body pursuant
to an authorization granted in accordance with Section 152 of the General Corporation Law of the State of Delaware (the &ldquo;<B><I>DGCL</I></B>&rdquo;),
(ii) that no more than 9,232,814 Shares will be sold under the Purchase Agreement and (iii) that the price at which the Shares
are sold will equal or exceed the par value of the Shares. We express no opinion to the extent that future issuances of securities
of the Company and/or anti-dilution adjustments to outstanding securities of the Company cause the number of shares of Common Stock
outstanding or issuable upon conversion or exercise of outstanding securities of the Company to exceed the number of Shares then
issuable under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our opinion herein is expressed solely
with respect to the DGCL. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and
express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">55 Hudson Yards, New York, NY 10001 T: (212) 479-6000 F: (212)
479-6275 www.cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="tm2011380d1_ex5-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 2, 2020</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Page Two</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the basis of the foregoing and in reliance
thereon, and subject to the qualifications herein stated, we are of the opinion that the Shares, when sold and issued in accordance
with the Registration Statement the Prospectus and the Purchase Agreement, will be validly issued, fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the reference to our
firm under the captions &ldquo;Legal Matters&rdquo; in the Prospectus and to the filing of this opinion as an exhibit to a current
report of the Company on Form 8-K to be filed with the Commission for incorporation by reference of this opinion into the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><B>Cooley LLP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: top">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Divakar Gupta</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Divakar Gupta</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">55 Hudson Yards, New York, NY 10001 T: (212) 479-6000 F: (212)
479-6275 www.cooley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>tm2011380d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B><U>Execution
Copy</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>COMMON
STOCK PURCHASE AGREEMENT</B></FONT> (the &ldquo;<B>Agreement</B>&rdquo;), dated as of February&nbsp;28, 2020 by and between <B>MARKER
THERAPEUTICS,&nbsp;INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>ASPIRE CAPITAL FUND, LLC</B>, an
Illinois limited liability company (the &ldquo;<B>Buyer</B>&rdquo;). Capitalized terms used herein and not otherwise defined herein
are defined in Section&nbsp;10 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>WHEREAS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms
and conditions set forth in this Agreement, the Company wishes to sell to the Buyer, and the Buyer wishes to buy from the Company,
up to Thirty Million Dollars ($30,000,000) of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B>Common
Stock</B>&rdquo;). The shares of Common Stock to be purchased hereunder are referred to herein as the &ldquo;<B>Purchase Shares</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>NOW
THEREFORE</B></FONT>, the Company and the Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in"><B>1.</B></TD><TD><B>PURCHASE OF COMMON STOCK.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms
and conditions set forth in this Agreement, the Company has the right to sell to the Buyer, and the Buyer has the obligation to
purchase from the Company, Purchase Shares as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Commencement
of Purchases of Common Stock</U>. Any time after Commencement (as defined below), the purchase and sale of Purchase Shares hereunder
may occur from time to time upon written notices by the Company to the Buyer on the terms and conditions as set forth herein following
the satisfaction of the conditions (the &ldquo;<B>Commencement</B></FONT><B>&rdquo;</B>) as set forth in Sections 6 and 7 below
(the date of satisfaction of such conditions, the &ldquo;<B>Commencement Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>The
Company&rsquo;s Right to Require Regular Purchases</U>. Subject to the terms and conditions of this Agreement, on any given Business
Day after the Commencement Date, the Company shall have the right but not the obligation to direct the Buyer by its delivery to
the Buyer of a Purchase Notice from time to time, and the Buyer thereupon shall have the obligation, to buy the number of Purchase
Shares specified in such notice, up to 100,000 Purchase Shares, on such Business Day (as long as such notice is delivered on or
before 5:</FONT>00 p.m.<FONT>&nbsp;Eastern time</FONT> on such Business Day) (each such purchase,
a &ldquo;<B>Regular Purchase</B>&rdquo;) at the Purchase Price on the Purchase Date; however, in no event shall the Purchase Amount
of a Regular Purchase exceed Five Hundred Thousand Dollars ($500,000) per Business Day, unless the Buyer and the Company mutually
agree. The Company and the Buyer may mutually agree to increase the number of Purchase Shares that may be sold per Regular Purchase
to as much as an additional 2,000,000 Purchase Shares per Business Day. The Company may deliver additional Purchase Notices to
the Buyer from time to time <FONT>so long as the most recent purchase has been completed. </FONT>
The share amounts in this Section&nbsp;1(b)&nbsp;shall be appropriately adjusted for any reorganization, recapitalization, non-cash
dividend, stock split, reverse stock split or other similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>VWAP
Purchases</U>. Subject to the terms and conditions of this Agreement, in addition to purchases of Purchase Shares as
described in Section&nbsp;1(b)&nbsp;above, with one Business Day&rsquo;s prior written notice </FONT>(as long as such notice
is delivered on or before 5:00 p.m.&nbsp;Eastern time on the Business Day immediately preceding the VWAP Purchase Date), the
Company shall also have the right but not the obligation to direct the Buyer by the Company&rsquo;s delivery to the Buyer of
a VWAP Purchase Notice from time to time, and the Buyer thereupon shall have the obligation, to buy the VWAP Purchase Share
Percentage of the trading volume of the Common Stock on the VWAP Purchase Date up to the VWAP Purchase Share Volume Maximum
on the VWAP Purchase Date (each such purchase, a &ldquo;<B>VWAP Purchase</B>&rdquo;) at the VWAP Purchase Price. The Company
may deliver a VWAP Purchase Notice to the Buyer on or before 5:00 p.m.&nbsp;Eastern time on a date on which the Company also
submitted a Purchase Notice for a Regular Purchase of at least 100,000 Purchase Shares to the Buyer. The share amount in the
prior sentence shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split,
reverse stock split, or other similar transaction. <FONT STYLE="font-family: Times New Roman, Times, Serif">A VWAP Purchase
shall automatically be deemed completed at such time on the VWAP Purchase Date that the Sale Price falls below the VWAP
Minimum Price Threshold; in such circumstance, the VWAP Purchase Amount shall be calculated using (i)&nbsp;the VWAP Purchase
Share Percentage of the aggregate shares traded on the Principal Market for such portion of the VWAP Purchase Date prior to
the time that the Sale Price fell below the VWAP Minimum Price Threshold and (ii)&nbsp;a VWAP Purchase Price calculated using
the volume weighted average price of Common Stock sold during such portion of the VWAP Purchase Date prior to the time that
the Sale Price fell below the VWAP Minimum Price Threshold. Each VWAP Purchase Notice must be accompanied by instructions to
the Company&rsquo;s <FONT>Transfer</FONT> Agent to immediately issue to the Buyer an amount of
Common Stock equal to the VWAP Purchase Share Estimate, a good faith estimate by the Company of the number of Purchase Shares
that the Buyer shall have the obligation to buy pursuant to the VWAP Purchase Notice. In no event shall the Buyer, pursuant
to any VWAP Purchase, purchase a number of Purchase Shares that exceeds the VWAP Purchase Share Estimate issued on the VWAP
Purchase Date in connection with such VWAP Purchase Notice; however, the Buyer will immediately return to the Company any
amount of Common Stock issued pursuant to the VWAP Purchase Share Estimate that exceeds the number of Purchase Shares the
Buyer actually purchases in connection with such VWAP Purchase. Upon completion of each VWAP Purchase Date, the Buyer shall
submit to the Company a confirmation of the VWAP Purchase in form and substance reasonably acceptable to the Company. The
Company may deliver additional VWAP Purchase Notices to the Buyer from time to time so long as the most recent purchase has
been completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
for Purchase Shares</U>. For each Regular Purchase, the Buyer shall pay to the Company an amount equal to the Purchase Amount as
full payment for such Purchase Shares via wire transfer of immediately available funds on the same Business Day that the Buyer
receives such Purchase Shares. For each VWAP Purchase, the Buyer shall pay to the Company an amount equal to the VWAP Purchase
Amount as full payment for such Purchase Shares via wire transfer of immediately available funds on the second Business Day following
the VWAP Purchase Date. All payments made under this Agreement shall be made in lawful money of the United States of America via
wire transfer of immediately available funds to such account as the Company may from time to time designate by written notice in
accordance with the provisions of this Agreement. Whenever any amount expressed to be due by the terms of this Agreement is due
on any day that is not a Business Day, the same shall instead be due on the next succeeding day that is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Price Floor</U>. The Company and the Buyer shall not effect any sales under this Agreement on any Purchase Date where the Closing
Sale Price is less than the Floor Price. &ldquo;<B>Floor Price</B>&rdquo; means $0.25 per share of Common Stock, which shall not
be adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Records
of Purchases</U>. The Buyer and the Company shall each maintain records showing the remaining Available Amount at any given time
and the dates and Purchase Amounts for each purchase, or shall use such other method reasonably satisfactory to the Buyer and the
Company to reconcile the remaining Available Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>.
The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance and delivery
of any shares of Common Stock to the Buyer made under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance
with Principal Market Rules</U>. Notwithstanding anything in this Agreement to the contrary, and in addition to the
limitations set forth in Section&nbsp;1(e), the total number of shares of Common Stock that may be issued under this
Agreement, including the Commitment Shares (as defined in Section&nbsp;4(e)&nbsp;hereof), shall be limited to 9,232,814
shares of Common Stock (the &ldquo;<B>Exchange Cap</B>&rdquo;), which equals 19.99% of the Company&rsquo;s outstanding shares
of Common Stock as of the date hereof, unless stockholder approval is obtained to issue more than such 19.99%. The Exchange
Cap shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock
split or other similar transaction. The foregoing limitation shall not apply if stockholder approval has not been obtained
and at any time the Exchange Cap is reached and at all times thereafter the average price paid for all shares of Common Stock
issued under this Agreement is equal to or greater than $2.41 (the &ldquo;<B>Minimum Price</B>&rdquo;), a price equal to the
lower of (1)&nbsp;the Closing Sale Price immediately preceding the execution of this Agreement or (2)&nbsp;the arithmetic
average of the five (5)&nbsp;Closing Sale Prices for the Common Stock immediately preceding the execution of this Agreement
(in such circumstance, for purposes of the Principal Market, the transaction contemplated hereby would not be &ldquo;below
market&rdquo; and the Exchange Cap would not apply). The Minimum Price shall be appropriately adjusted for any
reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction.
Notwithstanding the foregoing, the Company shall not be required or permitted to issue, and the Buyer shall not be required
to purchase, any shares of Common Stock under this Agreement if such issuance would breach the Company's obligations under
the rules&nbsp;or regulations of the Principal Market. The Company may, in its sole discretion, determine whether to obtain
stockholder approval to issue more than 19.99% of its outstanding shares of Common Stock hereunder if such issuance would
require stockholder approval under the rules&nbsp;or regulations of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Beneficial
Ownership Limitation</U>. The Company shall not issue, and the Buyer shall not purchase any shares of Common Stock under this Agreement,
if such shares proposed to be issued and sold, when aggregated with all other shares of Common Stock then owned beneficially (as
calculated pursuant to Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>1934 Act</B>&rdquo;)
and Rule&nbsp;13d-3 promulgated thereunder) by the Buyer and its affiliates would result in the beneficial ownership by the Buyer
and its affiliates of more than 19.99% of the then issued and outstanding shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Buyer represents
and warrants to the Company that as of the date hereof and as of the Commencement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment
Purpose</U>. The Buyer is entering into this Agreement and acquiring the Commitment Shares and the Purchase Shares (the Purchase
Shares and the Commitment Shares are collectively referred to herein as the &ldquo;<B>Securities</B>&rdquo;), for its own account
for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof; provided
however, by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or other
specific term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accredited
Investor Status</U>. The Buyer is an &ldquo;accredited investor&rdquo; as that term is defined in Rule&nbsp;501(a)(3)&nbsp;of Regulation
D of the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<U>Intentionally
Omitted</U>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Information</U>.
The Buyer has been furnished with all materials relating to the business, finances and operations of the Company and materials
relating to the offer and sale of the Securities that have been reasonably requested by the Buyer, including, without limitation,
the SEC Documents (as defined in Section&nbsp;3(f)&nbsp;hereof). The Buyer understands that its investment in the Securities involves
a high degree of risk. The Buyer (i)&nbsp;is able to bear the economic risk of an investment in the Securities including a total
loss, (ii)&nbsp;has such knowledge and experience in financial and business matters that it is capable of evaluating the merits
and risks of the proposed investment in the Securities and (iii)&nbsp;has had an opportunity to ask questions of and receive answers
from the officers of the Company concerning the financial condition and business of the Company and other matters related to an
investment in the Securities. Neither such inquiries nor any other due diligence investigations conducted by the Buyer or its representatives
shall modify, amend or affect the Buyer&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in
Section&nbsp;3 below. The Buyer has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to its acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Governmental Review</U>. The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment
in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<U>Intentionally
Omitted</U>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT><U>Organization</U>.
The Buyer is a limited liability company duly organized and validly existing in good standing under the laws of the jurisdiction
in which it is organized, and has the requisite organizational power and authority to own its properties and to carry on its business
as now being conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Validity;
Enforcement</U>. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Buyer and is a valid
and binding agreement of the Buyer enforceable against the Buyer in accordance with its terms, subject as to enforceability to
(i)&nbsp;general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other
similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights and remedies <FONT>and
(ii)&nbsp;public policy underlying any law, rule&nbsp;or regulation (including any federal or state securities law, rule&nbsp;or
regulation) with regards to indemnification, contribution or exculpation. The execution and delivery of the Transaction Documents
(as defined in Section&nbsp;3(b)&nbsp;hereof) by the Buyer and the consummation by it of the transactions contemplated hereby and
thereby do not conflict with the Buyer&rsquo;s certificate of organization or operating agreement or similar documents, and do
not require further consent or authorization by the Buyer, its managers or its members</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Residency</U>.
The Buyer is <FONT>a resident </FONT></FONT>of the State of Illinois.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Prior Short Selling</U>. The Buyer represents and warrants to the Company that at no time prior to the date of this Agreement has
any of the Buyer, its agents, representatives or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly,
any (i)&nbsp;&ldquo;short sale&rdquo; (as such term is defined in Section&nbsp;242.200 of Regulation SHO of the 1934 Act) of the
Common Stock or (ii)&nbsp;hedging transaction, which establishes a net short position with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company represents
and warrants to the Buyer that as of the date hereof and as of the Commencement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization
and Qualification</U>. The Company and its &ldquo;Subsidiaries&rdquo; (which for purposes of this Agreement means any entity in
which the Company, directly or indirectly, owns more <FONT>than 50%</FONT> of the voting stock or
capital stock or other similar equity interests) are corporations or limited liability companies duly organized and validly existing
in good standing under the laws of the jurisdiction in which they are incorporated or organized, and have the requisite corporate
or organizational power and authority to own their properties and to carry on their business as now being conducted. Each of the
Company and its Subsidiaries is duly qualified as a foreign corporation or limited liability company to do business and is in good
standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification
necessary, except to the extent that the failure to be so qualified or be in good standing could not reasonably be expected to
have a Material Adverse Effect. As used in this Agreement, &ldquo;Material Adverse Effect&rdquo; means any material adverse effect
on any of: (i)&nbsp;the business, properties, assets, operations, results of operations or financial condition of the Company and
its Subsidiaries, if any, taken as a whole, or (ii)&nbsp;the authority or ability of the Company to perform its obligations under
the Transaction Documents. The Company has no material Subsidiaries except as set forth on Schedule 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization;
Enforcement; Validity</U>. (i)&nbsp;The Company has the requisite corporate power and authority to enter into and perform its
obligations under this Agreement, the Registration Rights Agreement and each of the other agreements entered into by the
parties on the Commencement Date and attached hereto as exhibits to this Agreement (collectively, the &ldquo;<B>Transaction
Documents</B>&rdquo;), and to issue the Securities in accordance with the terms hereof and thereof, (ii)&nbsp;the execution
and delivery of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby
and thereby, including without limitation, the issuance of the Commitment Shares and the reservation for issuance and the
issuance of the Purchase Shares issuable under this Agreement, have been duly authorized by the Company&rsquo;s Board of
Directors or duly authorized committee thereof, do not conflict with the Company&rsquo;s Certificate of Incorporation or
Bylaws (as defined below), and do not require further consent or authorization by the Company, its Board of Directors, except
as set forth in this Agreement, or its <FONT>stockholders </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(other
than as contemplated by Section&nbsp;1(h)&nbsp;hereof), (iii)&nbsp;this Agreement has been, and each other Transaction
Document shall be on the Commencement Date, duly executed and delivered by the Company and (iv)&nbsp;this Agreement
constitutes, and each other Transaction Document upon its execution on behalf of the Company, shall constitute, the valid and
binding obligations of the Company enforceable against the Company in accordance with their terms, except as such
enforceability may be limited by <FONT>(y)&nbsp;</FONT>general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting
generally, the enforcement of creditors' rights and remedies <FONT>and (z)&nbsp;public policy
underlying any law, rule&nbsp;or regulation (including any federal or state securities law, rule&nbsp;or regulation) with
regards to indemnification, contribution or exculpation</FONT>. The Board of Directors of the Company or duly authorized
committee thereof has approved the resolutions (the &ldquo;<B>Signing Resolutions</B>&rdquo;) substantially in the form as
set forth as Exhibit&nbsp;B attached hereto to authorize this Agreement and the transactions contemplated hereby. The Signing
Resolutions are valid, in full force and effect and have not been modified or supplemented in any <FONT>material
respect</FONT>. The Company has delivered to the Buyer a true and correct copy of the Signing Resolutions as approved by the
Board of Directors of the Company or an appropriate Board committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>.
As of the date hereof, the authorized capital stock of the Company consists of (i)&nbsp;</FONT>150,000,000 shares of Common
Stock, par value $0.001, of which as of the date hereof, 46,187,165 shares are issued and outstanding, zero shares are held
as treasury shares, 8,000,000 shares are reserved for future issuance pursuant to the Company&rsquo;s equity incentive plans,
of which approximately 2,500,000 shares remain available for future option grants or stock awards, and approximately
21,800,000 shares are issuable and reserved for issuance pursuant to securities (other than stock options or equity based
awards issued pursuant to the Company&rsquo;s stock incentive plans) exercisable or exchangeable for, or convertible into,
shares of Common Stock, and (ii)&nbsp;5,000,000 shares of preferred stock, with per share liquidation preferences set forth
on Schedule 3(c), of which as of the date hereof zero shares are issued and outstanding. All of such outstanding shares have
been, or upon issuance will be, validly issued and are fully paid and non-assessable. Except as disclosed in Schedule 3(c),
(i)&nbsp;no shares of the Company&rsquo;s capital stock are subject to preemptive rights or any other similar rights or any
liens or encumbrances suffered or permitted by the Company, (ii)&nbsp;there are no outstanding debt securities of the Company
or any of its Subsidiaries, (iii)&nbsp;there are no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of
the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any
of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its
Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries,
(iv)&nbsp;there are no material agreements or arrangements under which the Company or any of its Subsidiaries is obligated to
register the sale of any of their securities under the 1933 Act (except the Registration Rights Agreement), (v)&nbsp;there
are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or
similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of
its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries, (vi)&nbsp;there are
no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the
Securities as described in this Agreement and (vii)&nbsp;the Company does not have any stock appreciation rights or
 &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. The Company has furnished or made available
to the Buyer true and correct copies of the Company&rsquo;s Certificate of Incorporation, as amended and as in effect on the
date hereof (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), and the Company&rsquo;s Bylaws, as amended and as in
effect on the date hereof (the &ldquo;<B>Bylaws</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of Securities</U>. The Commitment Shares have been duly authorized and, upon issuance in accordance with the terms hereof, the
Commitment Shares shall be (i)&nbsp;validly issued, fully paid and non-assessable and (ii)&nbsp;free from all taxes, liens and
charges with respect to the issuance thereof. Upon issuance and payment therefore in accordance with the terms and conditions of
this Agreement, the Purchase Shares shall be validly issued, fully paid and non-assessable and free from all taxes, liens and charges
with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts</U>. Except as disclosed in Schedule 3(e), the execution, delivery and performance of the Transaction Documents by the
Company and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation,
the reservation for issuance and issuance of the Purchase Shares) will not (i)&nbsp;result in a violation of the Certificate of
Incorporation<FONT>, any Certificate of Designations, Preferences and Rights of any outstanding
series of preferred stock of the Company</FONT> or the Bylaws or (ii)<FONT>&nbsp;conflict with,
or</FONT> constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to
others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the
Company or any of its Subsidiaries is a party, or result, to the Company&rsquo;s knowledge, in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws and regulations and the rules&nbsp;and regulations of the
Principal Market applicable to the Company or any of its Subsidiaries) or by which any property or asset of the Company or any
of its Subsidiaries is bound or affected, except in the case of <FONT>conflicts, </FONT>defaults,
terminations, amendments, accelerations, cancellations and violations under clause (ii), </FONT>which could not reasonably be expected
to result in a Material Adverse Effect. Except as disclosed in Schedule 3(e), neither the Company nor its Subsidiaries is in violation
of any term of or in default under its Certificate of Incorporation<FONT>, any Certificate of Designation,
Preferences and Rights of any outstanding series of preferred stock of the Company</FONT> or Bylaws or their organizational charter
or bylaws, respectively. Except as disclosed in Schedule 3(e), neither the Company nor any of its Subsidiaries is in violation
of any term of or is in default under any material contract, agreement, mortgage, indebtedness, indenture, instrument, judgment,
decree or order or any statute, rule&nbsp;or regulation applicable to the Company or its Subsidiaries, except for possible <FONT>violations</FONT>,
defaults, terminations or amendments <FONT>that</FONT> would not reasonably be expected to have
a Material Adverse Effect. The business of the Company and its Subsidiaries is not being conducted, and shall not be conducted,
in violation of any law, ordinance, or regulation of any governmental entity, except for possible violations, the sanctions for
which either individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect. Except as specifically
contemplated by this Agreement<FONT>, reporting obligations under the 1934 Act,</FONT> or as required
under the 1933 Act or applicable state securities laws <FONT>or the filing of a Listing of Additional
Shares Notification Form&nbsp;with the Principal Market</FONT>, the Company is not required to obtain any consent, authorization
or order of, or make any filing or registration with, any court or governmental agency or any regulatory or self-regulatory agency
in order for it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents in accordance
with the terms hereof or thereof. Except as disclosed in Schedule 3(e)<FONT>&nbsp;and for reporting
obligations under the 1934 Act</FONT>, all consents, authorizations, orders, filings and registrations which the Company is required
to obtain pursuant to the preceding sentence shall be obtained or effected on or prior to the Commencement Date. Except as disclosed
in Schedule 3(e), the Company is not subject to any notices or actions from or to the Principal Market <FONT>other
than routine matters incident to listing on the Principal Market and not involving a violation of the rules&nbsp;of the Principal
Market</FONT>. Except as disclosed in Schedule 3(e), to the Company&rsquo;s knowledge, the Principal Market has not commenced any
delisting proceedings against the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC
Documents; Financial Statements</U>. Except as disclosed in Schedule 3(f), since September&nbsp;30, 2018, the Company has
filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the
reporting requirements of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits included therein
and financial statements and schedules thereto and documents incorporated by reference therein being hereinafter referred to
as the &ldquo;<B>SEC Documents</B>&rdquo;). As of their respective dates (except as they have been correctly amended), the
SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules&nbsp;and regulations of
the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed
with the SEC (except as they may have been properly amended), contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. As of their respective dates (except as they have been properly
amended), the financial statements of the Company included in the SEC Documents complied as to form in all material respects
with applicable accounting requirements and the published rules&nbsp;and regulations of the SEC with respect thereto. Such
financial statements have been prepared in accordance with generally accepted accounting principles, consistently applied,
during the periods involved (except (i)&nbsp;as may be otherwise indicated in such financial statements or the notes thereto
or (ii)&nbsp;in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof
and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to
normal year-end audit adjustments). Except as disclosed in Schedule 3(f)&nbsp;or routine correspondence, such as comment
letters and notices of effectiveness in connection with previously filed registration statements <FONT>or
periodic reports publicly available on EDGAR, to the Company&rsquo;s knowledge</FONT>, the Company or any of its <FONT>Subsidiaries </FONT>are
not on the date hereof the subject of any inquiry, investigation or action by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Certain Changes</U>. Except as disclosed in Schedule 3(g), since September&nbsp;30, 2019, there has been no material adverse
change in the business, properties, operations, financial condition or results of operations of the Company or its Subsidiaries
taken as a whole. For purposes of this Agreement, neither a decrease in cash or cash equivalents or in the market price of the
Common Stock nor losses incurred in the ordinary course of the Company&rsquo;s business shall be deemed or considered a material
adverse change. The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant
to any Bankruptcy Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors
intend to initiate involuntary bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to
pay its debts as they become due<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Litigation</U>. </FONT>Except as disclosed in Schedule 3(h), t<FONT>o the Company&rsquo;s knowledge,
there</FONT> is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company or any of its Subsidiaries, threatened against
the Company, the Common Stock or any of the Company&rsquo;s Subsidiaries or any of the Company&rsquo;s or the Company&rsquo;s Subsidiaries&rsquo;
officers or directors in their capacities as such, which could reasonably be expected to have a Material Adverse Effect (each,
an &ldquo;<B>Action</B>&rdquo;). A description of each such Action, if any, is set forth in Schedule 3(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acknowledgment
Regarding Buyer&rsquo;s Status</U>. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of arm&rsquo;s
length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The Company further
acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by the Buyer or
any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and
thereby is merely incidental to the Buyer&rsquo;s purchase of the Securities. The Company further represents to the Buyer that
the Company&rsquo;s decision to enter into the Transaction Documents has been based solely on the independent evaluation by the
Company and its representatives and advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual
Property Rights</U>. To the Company&rsquo;s knowledge, the Company and its Subsidiaries own or possess adequate rights or
licenses to use all material trademarks, trade names, service marks, service mark registrations, service names, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual
property rights (collectively, &ldquo;<B>Intellectual Property</B>&rdquo;) necessary to conduct their respective businesses
as now conducted, except as set forth in Schedule 3(j)&nbsp;or to the extent that the failure to own, possess, license or
otherwise hold adequate rights to use Intellectual Property would not, individually or in the aggregate, have a Material
Adverse Effect. Except as disclosed in Schedule 3(j), <FONT>to the Company&rsquo;s
knowledge,</FONT> none of the Company&rsquo;s active and registered Intellectual Property have expired or terminated, or, by
the terms and conditions thereof, <FONT>will </FONT>expire or terminate within two years from
the date of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect. The Company and its
Subsidiaries do not have any knowledge of any infringement by the Company or its Subsidiaries of any Intellectual Property of
others and, except as set forth on Schedule 3(j), there is no claim, action or proceeding being made or brought against, or
to the Company&rsquo;s knowledge, being threatened against, the Company or its Subsidiaries regarding Intellectual Property,
which could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental
Laws</U>. <FONT>To the Company&rsquo;s knowledge, </FONT>the Company and its Subsidiaries (i)&nbsp;are
in material compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection
of human health and safety <FONT>or</FONT> the environment <FONT>and
with respect to</FONT> hazardous or toxic substances or wastes, pollutants or contaminants (&ldquo;<B>Environmental Laws</B>&rdquo;),
(ii)&nbsp;have received all material permits, licenses or other approvals required of them under applicable Environmental Laws
to conduct their respective businesses and (iii)&nbsp;are in material compliance with all terms and conditions of any such permit,
license or approval, except where, in each of the three foregoing clauses, the failure to so comply or receive such approvals could
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title</U>.
The Company and its Subsidiaries have good and marketable title to all personal property owned by them that is material to the
business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as
are described in Schedule 3(<FONT STYLE="background-color: aqua">l</FONT>)&nbsp;or such as do not materially affect the value of
such property and do not interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries
<FONT>or could not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect</FONT>. Any real property and facilities held under lease by the Company and any of its Subsidiaries<FONT>,
to the Company&rsquo;s knowledge,</FONT> are held by them under valid, subsisting and enforceable leases with such exceptions as
are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and
its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
</FONT>The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as management of the Company believes to be reasonable and customary in the businesses in which the
Company and its Subsidiaries are engaged. To the Company&rsquo;s knowledge, since January&nbsp;1, 2018, neither the Company nor
any such Subsidiary has been refused any insurance coverage sought or applied for and neither the Company nor any such Subsidiary,
to the Company&rsquo;s knowledge, will be unable to renew its existing insurance coverage as and when such coverage expires or
to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would <FONT>not
reasonably be expected to have a Material Adverse Effect</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory
Permits</U>. The Company and its Subsidiaries possess all material certificates, authorizations and permits issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct their respective businesses as currently conducted, except
when the failure to so possess such certificates, authorizations or permits could not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any written notice
of proceedings relating to the revocation or modification of any such <FONT>material</FONT> certificate,
authorization or permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax
Status</U>. The Company and each of its Subsidiaries has made or filed all federal and state income and all other material
tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that
the Company and each of its Subsidiaries has set aside on its books reserves reasonably adequate for the payment of all
unpaid and unreported taxes or filed valid extensions) and has paid all taxes and other governmental assessments and charges
that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being
contested in good faith and has set aside on its books reserves reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. <FONT>To the
Company&rsquo;s knowledge, there </FONT>are no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions
With Affiliates</U>. Except as set forth on Schedule 3(p), and other than (i)&nbsp;the grant or exercise of stock options <FONT>or
any other equity securities offered </FONT>pursuant to duly adopted stock or incentive compensation plans as </FONT>disclosed on
Schedule 3(c)&nbsp;and (ii)&nbsp;employment or indemnification agreements approved by the Board of Directors of the Company, none
of the officers, directors or employees of the Company is on the date hereof a party to any transaction with the Company or any
of its Subsidiaries (other than for services as employees, officers and directors <FONT>and reimbursement
for expenses incurred on behalf of the Company</FONT>), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other
entity in which any officer, director, or any such employee has <FONT>a material</FONT> interest
or is an officer, director, trustee or <FONT>general </FONT>partner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application
of Takeover Protections</U>. The Company and its board of directors have taken or will take prior to the Commencement Date all
necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the <FONT>Certificate</FONT>
of Incorporation or the laws of the state of its incorporation, other than Section&nbsp;203 of the Delaware General Corporation
Law, which is or could become applicable to the Buyer as a result of the transactions contemplated by this Agreement, including,
without limitation, the Company&rsquo;s issuance of the Securities and the Buyer&rsquo;s ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement</U>. The Shelf Registration Statement (as defined in Section&nbsp;4(a)&nbsp;hereof) has been declared effective by the
SEC, and no stop order has been issued or is pending or, to the knowledge of the Company, threatened by the SEC with respect thereto.
As of the date hereof, the Company has a dollar amount of securities registered and unsold under the Shelf Registration Statement,
which is not less than the sum of (i)&nbsp;the Available Amount and (ii)&nbsp;the market value of the Commitment Shares on the
date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>COVENANTS.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filing
of Form&nbsp;8-K and Prospectus Supplement</U>. The Company agrees that it shall, within the time required under the 1934 Act,
file a Current Report on Form&nbsp;8-K disclosing this Agreement and the transaction contemplated hereby. The Company shall file
within </FONT>two (2)&nbsp;Business Days from the date hereof a prospectus supplement to the Company&rsquo;s existing shelf registration
statement on Form&nbsp;S-3 (File No.&nbsp;333-232122, the &ldquo;<B>Shelf Registration Statement</B>&rdquo;) covering the sale
of the Commitment Shares and Purchase Shares (the &ldquo;<B>Prospectus Supplement</B>&rdquo;) in accordance with the terms of the
Registration Rights Agreement between the Company and the Buyer, dated as of the date hereof (the &ldquo;<B>Registration Rights
Agreement</B>&rdquo;). <FONT>The Company shall use its reasonable best efforts to keep the Shelf
Registration Statement and any New Registration Statement (as defined in the Registration Rights Agreement) effective pursuant
to Rule&nbsp;415 promulgated under the 1933 Act and available for sales of all Securities to the Buyer until such time as (i)&nbsp;it
no longer qualifies to make sales under the Shelf Registration Statement (which shall be understood to include the inability of
the Company to immediately register sales of Securities to the Buyer under the Shelf Registration Statement or any New Registration
Statement pursuant to General Instruction I.B.6 of Form&nbsp;S-3), (ii)&nbsp;the date on which all the Securities have been sold
under this Agreement and no Available Amount remains thereunder, or (iii)&nbsp;this Agreement has been terminated. </FONT>The Shelf
Registration Statement (including any amendments or supplements thereto and prospectuses or prospectus supplements, including the
Prospectus Supplement, contained therein) shall not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were
made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Blue
Sky</U>. The Company shall take such action, if any, as is reasonably necessary in order to obtain an exemption for or to qualify
(i)&nbsp;the initial sale of the Securities to the Buyer under this Agreement and (ii)&nbsp;any subsequent sale of the Securities
by the Buyer, in each case, under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States in such
states as is reasonably requested by the Buyer from time to time, and shall provide evidence of any such action so taken to the
Buyer at its written request; <I>provided, however, </I>that the Company shall not be obligated to file any general consent to
service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so
qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing</U>.
The Company shall promptly secure the listing of all of the Securities upon each national securities exchange and automated quotation
system <FONT>that requires an application by the Company for listing</FONT>, if any, upon which
shares of Common Stock are then listed (subject to official notice of issuance) and shall maintain <FONT>such
listing</FONT>, so long as any other shares of Common Stock shall be so listed. The Company shall use its reasonable best efforts
to maintain the Common Stock&rsquo;s listing on the Principal Market in accordance with the requirements of the Registration Rights
Agreement. Neither the Company nor any of its Subsidiaries shall take any action that would be reasonably expected to result in
the delisting or suspension of the Common Stock on the Principal Market, unless the Common Stock is immediately thereafter traded
on the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital
Market. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
on Short Sales and Hedging Transactions</U>. The Buyer agrees that beginning on the date of this Agreement and ending on the date
of termination of this Agreement as provided in Section&nbsp;11(k), the Buyer and its agents, representatives and affiliates shall
not in any manner whatsoever enter into or effect, directly or indirectly, any (i)&nbsp;&ldquo;short sale&rdquo; (as such term
is defined in Section&nbsp;242.200 of Regulation SHO of the 1934 Act) of the Common Stock or (ii)&nbsp;hedging transaction, which
establishes a net short position with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
of Commitment Shares</U>. In connection with the Commencement, the Company shall issue to the Buyer as consideration for the Buyer
entering into this Agreement 345,357 shares of Common Stock (the &ldquo;<B>Commitment Shares</B>&rdquo;). The Commitment Shares
shall be issued without any restrictive legend whatsoever or prior sale requirement<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Due
Diligence</U>. The Buyer shall have the right, from time to time as the Buyer may reasonably request, to perform reasonable due
diligence on the Company during normal business hours and subject to reasonable prior notice to the Company. The Company and its
officers and employees shall provide information and reasonably cooperate with the Buyer in connection with any reasonable request
by the Buyer related to the Buyer&rsquo;s due diligence of the Company, including, but not limited to, any such request made by
the Buyer in connection with (i)&nbsp;the filing of the prospectus supplement described in Section&nbsp;4(a)&nbsp;hereof and (ii)&nbsp;the
Commencement; provided, however, that at no time is the Company required to disclose material nonpublic information to the Buyer
<FONT>or breach any obligation of confidentiality or non-disclosure to a third party or make any
disclosure that could cause a waiver of attorney-client privilege</FONT>. Except as may be required by law, court order or governmental
authority, each party hereto agrees not to disclose any Confidential Information of the other party to any third party and shall
not use the Confidential Information of such other party for any purpose other than in connection with, or in furtherance of, the
transactions contemplated hereby; provided, that to the extent such disclosure is required by law, court order or governmental
authority, the receiving party shall provide the disclosing party with reasonable prior written notice of such disclosure and make
a reasonable effort to assist the disclosing party in obtaining a protective order preventing or limiting the disclosure and/or
requiring that the Confidential Information so disclosed be used only for the purposes for which the law, court order or governmental
authority requires. Each party hereto acknowledges that the Confidential Information shall remain the property of the disclosing
party and agrees that it shall take all reasonable measures to protect the secrecy of any Confidential Information disclosed by
the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Intentionally
omitted.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B>TRANSFER AGENT INSTRUCTIONS.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Purchase
Shares to be issued under this Agreement shall be issued without any restrictive legend unless the Buyer expressly consents otherwise.
The Company shall issue irrevocable instructions to the Transfer Agent, and any subsequent transfer agent, to issue Common Stock
in the name of the Buyer for the Purchase Shares (the &ldquo;<B>Irrevocable Transfer Agent Instructions&rdquo;</B>). The Company
warrants to the Buyer that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section&nbsp;5,
will be given by the Company to the Transfer Agent with respect to the Purchase Shares and that the Commitment Shares and the Purchase
Shares shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement
and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in"><B>6.</B></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO THE COMPANY&rsquo;S RIGHT TO COMMENCE SALES OF SHARES OF COMMON STOCK
                                                                     UNDER THIS AGREEMENT.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
right of the Company hereunder to commence sales of the Purchase Shares is subject to the satisfaction of each of the following
conditions on or before the Commencement Date (the date that the Company may begin sales of Purchase Shares</FONT>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer shall have executed each of the Transaction Documents and delivered the same to the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Buyer shall be true and correct as of the Commencement Date as though made at that time (except
for representations and warranties that speak as of a specific date, which shall be true and correct in all material respects as
of such specific date) and the Buyer shall have performed, satisfied and complied in all material respects with the covenants and
agreements required by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Commencement
Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Prospectus Supplement shall have been delivered to the Buyer and no stop order with respect to the registration statement covering
the sale of shares to the Buyer shall be pending or threatened by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in"><B>7.</B></TD><TD STYLE="text-align: justify"><B>CONDITIONS TO THE BUYER&rsquo;S OBLIGATION TO MAKE&#9;PURCHASES OF SHARES OF COMMON STOCK.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of the
Buyer to buy Purchase Shares under this Agreement is subject to the satisfaction of each of the following conditions on or before
the Commencement Date (the date that the Company may begin sales of Purchase Shares) and once such conditions have been initially
satisfied, there shall not be any ongoing obligation to satisfy such conditions after the Commencement has occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have executed each of the Transaction Documents and delivered the same to the Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Intentionally
Omitted.];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Common Stock shall be authorized for quotation on the Principal Market, trading in the Common Stock shall not have been within
the last 365 days suspended by the SEC or the Principal Market</FONT>, other than a general halt in trading in the Common Stock
by the Principal Market under halt codes indicating pending or released material news, and the Securities shall be approved for
listing upon the Principal Market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Buyer shall have received the opinion of the Company&rsquo;s legal counsel dated as of the Commencement Date in customary form
and substance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company shall be true and correct in all material respects (except to the extent that any
of such representations and warranties is already qualified as to materiality in Section&nbsp;3 above, in which case, such representations
and warranties shall be true and correct without further qualification) as of the date of this Agreement and as of the Commencement
Date as though made at that time (except for representations and warranties that speak as of a specific date, which shall be true
and correct in all material respects as of such specific date) and the Company shall have performed, satisfied and complied in
all material respects with the covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied
or complied with by the Company at or prior to the Commencement Date. The Buyer shall have received a certificate, executed by
the CEO, President or CFO of the Company, dated as of the Commencement Date, to the foregoing effect in the form attached hereto
as <B>Exhibit&nbsp;A</B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors of the Company or a duly authorized committee thereof shall have adopted resolutions substantially in the form
attached hereto as <B>Exhibit&nbsp;B</B> which shall be in full force and effect without any amendment or supplement thereto as
of the Commencement Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose
of effecting future purchases of Purchase Shares hereunder, 12,448,132 shares of Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Irrevocable Transfer Agent Instructions, in form acceptable to the Buyer shall have been signed by the Company and the Buyer and
shall have been delivered to the Transfer Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have delivered to the Buyer a certificate evidencing the incorporation and good standing of the Company in the State
of Delaware issued by the Secretary of State of the State of Delaware as of a date within ten (10)&nbsp;Business Days of the Commencement
Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Intentionally
Omitted.];</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have delivered to the Buyer a secretary&rsquo;s certificate executed by the Secretary of the Company, dated as of
the Commencement Date, in the form attached hereto as <B>Exhibit&nbsp;C</B>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Shelf Registration Statement shall have been declared effective under the 1933 Act by the SEC and no stop order with respect thereto
shall be pending or threatened by the SEC. The Company shall have prepared and delivered to the Buyer a final and complete form
of prospectus supplement, dated and current as of the Commencement Date, to be used in connection with any issuances of any Commitment
Shares or any Purchase Shares to the Buyer, and to be filed by the Company within </FONT>one (1)&nbsp;Business Day after the Commencement
Date pursuant to Rule&nbsp;424(b). The Company shall have made all filings under all applicable federal and state securities laws
necessary to consummate the issuance of the Commitment Shares and the Purchase Shares pursuant to this Agreement in compliance
with such laws;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Event of Default has occurred and is continuing, or any event which, after notice and/or lapse of time, would become an Event
of Default has occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or prior to the Commencement Date, the Company shall take all necessary action, if any, and such actions as reasonably
requested by the Buyer, in order to render inapplicable any control share acquisition, business combination, stockholder
rights plan or poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision
under the Certificate of Incorporation or the laws of the state of its incorporation, other than Section&nbsp;203 of the
Delaware General Corporation Law, that is or could become applicable to the Buyer as a result of the transactions
contemplated by this Agreement, including, without limitation, the Company's issuance of the Securities and the Buyer's
ownership of the Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company shall have provided the Buyer with the information reasonably requested by the Buyer in connection with its due diligence
requests made prior to, or in connection with, the Commencement, in accordance with the terms of Section&nbsp;4(f)&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in"><B>8.</B></TD><TD STYLE="text-align: justify"><B>INDEMNIFICATION.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of
the Buyer&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities hereunder and in addition to
all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and
hold harmless the Buyer and all of its affiliates, members, officers, directors, and employees, and any of the foregoing person&rsquo;s
agents or other representatives (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) (collectively, the &ldquo;<B>Indemnitees</B>&rdquo;) from and against any and all third-party actions, causes
of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective
of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
and documented attorneys&rsquo; fees and disbursements (the &ldquo;<B>Indemnified Liabilities</B>&rdquo;), incurred by any Indemnitee
as a result of, or arising out of, or relating to (a)&nbsp;any misrepresentation or breach of any representation or warranty made
by the Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (b)&nbsp;any
breach of any covenant, agreement or obligation of the Company contained in the Transaction Documents or any other certificate,
instrument or document contemplated hereby or thereby, or (c)&nbsp;any cause of action, suit or claim brought or made against
such Indemnitee and arising out of or resulting from the execution, delivery, performance or enforcement of the Transaction Documents
or any other certificate, instrument or document contemplated hereby or thereby, other than with respect to Indemnified Liabilities
which directly and primarily result from (A)&nbsp;a breach of any of the Buyer&rsquo;s representations and warranties, covenants
or agreements contained in this Agreement, or (B)&nbsp;the gross negligence, bad faith or willful misconduct of the Buyer or any
other Indemnitee. To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company
shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible
under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>9.</B></TD><TD STYLE="text-align: justify"><B>EVENTS OF DEFAULT.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An &ldquo;<B>Event
of Default</B>&rdquo; shall be deemed to have occurred at any time as any of the following events occurs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;during
any period in which the effectiveness of any registration statement is required to be maintained pursuant to the terms of the
Registration Rights Agreement, the effectiveness of such registration statement lapses for any reason (including, without limitation,
the issuance of a stop order) or is unavailable to the Company for the sale of all of the Registrable Securities (as defined in
the Registration Rights Agreement) to the Buyer in accordance with the terms of the Registration Rights Agreement, and such lapse
or unavailability continues for a period of ten (10)&nbsp;consecutive Business Days or for more than an aggregate of thirty (30)
Business Days in any 365-day period, which is not in connection with a post-effective amendment to any such registration statement
or the filing of a new registration statement; provided, however, that in connection with any post-effective amendment to such
registration statement or filing of a new registration statement that is required to be declared effective by the SEC, such lapse
or unavailability may continue for a period of no more than thirty (30) consecutive Business Days, which such period shall be
extended for an additional thirty (30) Business Days if the Company receives a comment letter from the SEC in connection therewith;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
suspension from trading or failure of the Common Stock to be listed on a Principal Market for a period of three (3)&nbsp;consecutive
Business Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
delisting of the Common Stock from the Principal Market, and the Common Stock is not immediately thereafter trading on the New
York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, or </FONT>the Nasdaq Capital
Market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
failure for any reason by the Transfer Agent to issue Purchase Shares to the Buyer within five (5)&nbsp;Business Days after the
applicable Purchase Date that the Buyer is entitled to receive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company&rsquo;s breach of any </FONT>representation or warranty (as of the dates made), covenant or other term or condition under
any Transaction Document if such breach could reasonably be expected to have a Material Adverse Effect and except, in the case
of a breach of a covenant which is reasonably curable, only if such breach continues uncured for a period of at least five (5)&nbsp;Business
Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
the Company pursuant to or within the meaning of any Bankruptcy Law; (A)&nbsp;commences a voluntary case, (B)&nbsp;consents to
the entry of an order for relief against it in an involuntary case, (C)&nbsp;consents to the appointment of a Custodian of it
or for all or substantially all of its property, (D)&nbsp;makes a general assignment for the benefit of its creditors or (E)&nbsp;becomes
insolvent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (A)&nbsp;is for relief against the Company
in an involuntary case, (B)&nbsp;appoints a Custodian of the Company or for all or substantially all of its property, or (C)&nbsp;orders
the liquidation of the Company or any Subsidiary; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if
at any time after the Commencement Date, the Exchange Cap is reached unless and until stockholder approval has been obtained pursuant
to Section&nbsp;1(h)&nbsp;hereof. The Exchange Cap shall be deemed to be reached at such time if, upon submission of a Purchase
Notice or VWAP Purchase Notice under this Agreement, the issuance of such shares of Common Stock would exceed the number of shares
of Common Stock which the Company may issue under this Agreement without breaching the Company&rsquo;s obligations under the rules&nbsp;or
regulations of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to any other rights and remedies
under applicable law and this Agreement, including the Buyer termination rights under Section&nbsp;11(k)&nbsp;hereof, so long
as an Event of Default has occurred and is continuing, or if any event which, after notice and/or lapse of time, would become
an Event of Default, has occurred and is continuing, or so long as the Closing Sale Price is below the Floor Price, the Company
may not require and the Buyer shall not be obligated to purchase any shares of Common Stock under this Agreement. If pursuant
to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding against
the Company, a Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes a
general assignment for the benefit of its creditors, (any of which would be an Event of Default as described in Sections 9(f),
9(g)&nbsp;and 9(h)&nbsp;hereof) this Agreement shall automatically terminate without any liability or payment to the Company without
further action or notice by any Person. No such termination of this Agreement under Section&nbsp;11(k)(i)&nbsp;shall affect the
Company&rsquo;s or the Buyer&rsquo;s obligations under this Agreement with respect to pending purchases and the Company and the
Buyer shall complete their respective obligations with respect to any pending purchases under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>10.</B></TD><TD STYLE="text-align: justify"><B>CERTAIN DEFINED TERMS.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this
Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>1933
Act</B>&rdquo; means the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Available
Amount</B>&rdquo; means initially Thirty Million Dollars ($30,000,000) in the aggregate which amount shall be reduced by the Purchase
Amount each time the Buyer purchases shares of Common Stock pursuant to Section&nbsp;1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Bankruptcy
Law</B>&rdquo; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day on which the Principal Market is open for trading during normal trading hours (i.e., 9:30 a.m.&nbsp;to
4:00 p.m.&nbsp;Eastern Time), including any day on which the Principal Market is open for trading for a period of time less than
the customary time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Closing
Sale Price</B>&rdquo; means the last closing trade price for the Common Stock on the Principal Market as reported by the Principal
Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Confidential
Information</B>&rdquo; </FONT>means any information disclosed by either party to the other party, either directly or indirectly,
in writing, orally or by inspection of tangible objects (including, without limitation, documents, prototypes, samples, protocols,
development plans, commercialization plans, compounds, formulations, preclinical study and clinical trial results, plant and equipment),
which is designated as &quot;Confidential,&quot; &quot;Proprietary&quot; or some similar designation. Information communicated
orally shall be considered Confidential Information if such information is expressly identified as Confidential Information at
the time of such initial disclosure and confirmed in writing as being Confidential Information within ten (10)&nbsp;Business Days
after the initial disclosure. Confidential Information may also include information disclosed to a disclosing party by third parties.
Confidential Information shall not, however, include any information which (i)&nbsp;was publicly known and made generally available
in the public domain prior to the time of disclosure by the disclosing party; (ii)&nbsp;becomes publicly known and made generally
available after disclosure by the disclosing party to the receiving party through no action or inaction of the receiving party
or its affiliates; (iii)&nbsp;is already in the possession of the receiving party at the time of disclosure by the disclosing party
as shown by the receiving party&rsquo;s files and records immediately prior to the time of disclosure; (iv)&nbsp;is obtained by
the receiving party from a third party without a breach of such third party&rsquo;s obligations of confidentiality; or (v)&nbsp;is
independently developed by the receiving party without use of or reference to the disclosing party&rsquo;s Confidential Information,
as shown by documents and other competent evidence in the receiving party&rsquo;s possession.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Custodian</B>&rdquo;
means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Maturity
Date</B>&rdquo; means the date that is thirty (30) months from the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Person</B>&rdquo;
means an individual or entity including any limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Principal
Market</B>&rdquo; means the Nasdaq Global Market; provided however, that in the event the Company&rsquo;s Common Stock is ever
listed or traded on the New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market,
or the Nasdaq</FONT> Capital Market, then the &ldquo;Principal Market&rdquo; shall mean such other market or exchange on which
the Company&rsquo;s Common Stock is then listed or traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Purchase
Amount</B>&rdquo; means, with respect to any particular purchase made hereunder, the portion of the Available Amount to be purchased
by the Buyer pursuant to Section&nbsp;1 hereof as set forth in a valid Purchase Notice or VWAP Purchase Notice which the Company
delivers to the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Purchase
Date</B>&rdquo; means, with respect to any Regular Purchase made hereunder, the Business Day of receipt by the Buyer of a valid
Purchase Notice that the Buyer is to buy Purchase Shares pursuant to Section&nbsp;1(b)&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Purchase
Notice</B>&rdquo; shall mean an irrevocable written notice from the Company to the Buyer directing the Buyer to buy Purchase Shares
pursuant to Section&nbsp;1(b)&nbsp;hereof as specified by the Company therein at the applicable Purchase Price on the Purchase
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Purchase
Price</B>&rdquo; means the lesser of (i)&nbsp;the lowest Sale Price of the Common Stock on the Purchase Date or (ii)&nbsp;the arithmetic
average of the three (3)&nbsp;lowest Closing Sale Prices for the Common Stock during the </FONT>ten (10)&nbsp;consecutive Business
Days ending on the Business Day immediately preceding such Purchase Date (to be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Sale
Price</B>&rdquo; means any trade price for the shares of Common Stock on the Principal Market during normal trading hours, as reported
by the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>SEC</B>&rdquo;
means the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>Transfer
Agent</B>&rdquo; means the transfer agent of the Company as set forth in Section&nbsp;11(f)&nbsp;hereof or such other person who
is then serving as the transfer agent for the Company in respect of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Minimum Price Threshold</B>&rdquo; means, with respect to any particular VWAP Purchase Notice, the Sale Price on the VWAP Purchase
Date equal to the greater of (i)&nbsp;80% of the Closing Sale Price on the Business Day immediately preceding the VWAP Purchase
Date or (ii)&nbsp;such higher price as set forth by the Company in the VWAP Purchase Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Amount</B>&rdquo; means, with respect to any particular VWAP Purchase Notice, the portion of the Available Amount to
be purchased by the Buyer pursuant to Section&nbsp;1(c)&nbsp;hereof pursuant to a valid VWAP Purchase Notice which requires the
Buyer to buy the VWAP Purchase Share Percentage of the aggregate shares traded on the Principal Market during normal trading hours
on the VWAP Purchase Date up to the VWAP Purchase Share Volume Maximum, subject to the VWAP Minimum Price Threshold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Date</B>&rdquo; means, with respect to any VWAP Purchase made hereunder, the Business Day following the receipt by the
Buyer of a valid VWAP Purchase Notice that the Buyer is to buy Purchase Shares pursuant to Section&nbsp;1(c)&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Notice</B>&rdquo; shall mean an irrevocable written notice from the Company to the Buyer directing the Buyer to buy Purchase
Shares on the VWAP Purchase Date pursuant to Section&nbsp;1(c)&nbsp;hereof as specified by the Company therein at the applicable
VWAP Purchase Price with the applicable VWAP Purchase Share Percentage specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Share Percentage</B>&rdquo; means, with respect to any particular VWAP Purchase Notice pursuant to Section&nbsp;1(c)&nbsp;hereof,
the percentage set forth in the VWAP Purchase Notice which the Buyer will be required to buy as a specified percentage of the aggregate
shares traded on the Principal Market during normal trading hours up to the VWAP Purchase Share Volume Maximum on the VWAP Purchase
Date subject to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&nbsp;1(c)&nbsp;hereof but in no
event shall this percentage exceed thirty percent (30%) of such VWAP Purchase Date&rsquo;s share trading volume of the Common Stock
on the Principal Market during normal trading hours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Price</B>&rdquo; means the lesser of (i)&nbsp;the Closing Sale Price on the VWAP Purchase Date; or (ii)&nbsp;</FONT>ninety-seven
percent (97%) of volume weighted average price for the Common Stock traded on the Principal Market during normal trading hours
on (A)&nbsp;the VWAP Purchase Date if the aggregate shares traded on the Principal Market on the VWAP Purchase Date have not exceeded
the VWAP Purchase Share Volume Maximum and the Sale Price of Common Stock has not fallen below the VWAP Minimum Price Threshold
(to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or
other similar transaction), or (B)&nbsp;the portion of the VWAP Purchase Date until such time as the sooner to occur of (1)&nbsp;the
time at which the aggregate shares traded on the Principal Market has exceeded the VWAP Purchase Share Volume Maximum, or (2)&nbsp;the
time at which the Sale Price of Common Stock falls below the VWAP Minimum Price Threshold (to be appropriately adjusted for any
reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Share Estimate</B>&rdquo; means the number of shares of Common Stock that the Company has in its sole discretion irrevocably
instructed its Transfer Agent to issue to the Buyer via the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated
Securities Transfer Program in connection with a VWAP Purchase Notice pursuant to Section&nbsp;1(c)&nbsp;hereof and issued to the
Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit Withdrawal At Custodian (DWAC) system on the
VWAP Purchase Date (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ldquo;<B>VWAP
Purchase Share Volume Maximum</B>&rdquo; means a number of shares of Common Stock traded on the Principal Market during normal
trading hours on the VWAP Purchase Date equal to: (i)&nbsp;the VWAP Purchase Share Estimate, divided by (ii)&nbsp;the VWAP Purchase
Share Percentage (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.6in; text-align: left"><B>11.</B></TD><TD STYLE="text-align: justify"><B>MISCELLANEOUS.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law; Jurisdiction; Jury Trial</U>. The corporate laws of the State of Delaware shall govern all issues concerning the relative
rights of the Company and its stockholders. All other questions concerning the construction, validity, enforcement and interpretation
of this Agreement and the other Transaction Documents shall be governed by the internal laws of the State of Illinois, without
giving effect to any choice of law or conflict of law provision or rule&nbsp;(whether of the State of Illinois or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Illinois. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of Chicago, for the adjudication of
any dispute hereunder or under the other Transaction Documents or in connection herewith or therewith, or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof
to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE, AND AGREES NOT TO
REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT
OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party;
provided that a facsimile or pdf (or other electronic reproduction) signature shall be considered due execution and shall be
binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or
PDF (or other electronic reproduction) signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. This Agreement and the Registration Rights Agreement supersede all other prior oral or written agreements between
the Buyer, the Company, their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this
Agreement, the other Transaction Documents and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. Each of the Company and
the Buyer acknowledges and agrees that it has not relied on, in any manner whatsoever, any representations or statements, written
or oral, other than as expressly set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered: (i)&nbsp;upon receipt, when delivered personally; (ii)&nbsp;upon receipt,
when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the
sending party); (iii)&nbsp;upon receipt, when sent by electronic message (provided the recipient responds to the message and confirmation
of both electronic messages are kept on file by the sending party); or (iv)&nbsp;one (1)&nbsp;Business Day after timely deposit
with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Marker Therapeutics,&nbsp;Inc.</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">3200 Southwest Freeway, Suite&nbsp;2240</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">Houston, TX 77027</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">Phone: 713-400-6400</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">Facsimile:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">Attention:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="1" STYLE="font: 10pt Times New Roman, Times, Serif">Email:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a copy (which
shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Cooley LLP</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">55 Hudson Yards</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">New York, NY 10001</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Telephone: </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">212-479-6474</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%">212-479-6275</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Divakar Gupta</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">dgupta@cooley.com</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Buyer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Aspire Capital Fund, LLC</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">155 North Wacker Drive, Suite&nbsp;1600</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Chicago,&nbsp;IL 60606</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">312-658-0400</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%">312-658-4005</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Steven G. Martin</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">smartin@aspirecapital.com</TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a copy to (which
shall not constitute delivery to the Buyer):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Morrison&nbsp;&amp; Foerster LLP</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">2000 Pennsylvania Avenue, NW, Suite&nbsp;6000</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Washington, DC 20006</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">202-778-1611</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%">Facsimile:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%">202-887-0763</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Martin P. Dunn,&nbsp;Esq.</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">mdunn@mofo.com</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 21; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Transfer
Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 88%; margin-left: 1in">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">American Stock Transfer&nbsp;&amp; Trust Company, LLC</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">6201 15th Avenue</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Brooklyn, NY 11219</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%">Telephone:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%">972-684-5308</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Attention:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Bill Torre</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">wtorre@astfinancial.com</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or at such other address and/or facsimile
number and/or to the attention of such other person as the recipient party has specified by written notice given to each other
party at least one (1)&nbsp;Business Day prior to the effectiveness of such change. Written confirmation of receipt (A)&nbsp;given
by the recipient of such notice, consent or other communication, (B)&nbsp;mechanically or electronically generated by the sender&rsquo;s
facsimile machine containing the time, date, and recipient facsimile number, (C)&nbsp;electronically generated by the sender&rsquo;s
electronic mail containing the time, date and recipient email address or (D)&nbsp;provided by a nationally recognized overnight
delivery service, shall be rebuttable evidence of receipt in accordance with clause (i), (ii), (iii)&nbsp;or (iv)&nbsp;above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
assigns. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Buyer, including by merger or consolidation; </FONT>provided, however, that any transaction, whether by merger, reorganization,
restructuring, consolidation, financing or otherwise, whereby the Company remains the surviving entity immediately after such transaction
shall not be deemed a succession or assignment. The Buyer may not assign its rights or obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Publicity</U>.
The Buyer shall have the right to approve before issuance any press release, SEC filing or any other public disclosure made by
or on behalf of the Company whatsoever with respect to, in any manner, the Buyer, its purchases hereunder or any aspect of this
Agreement or the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval
of the Buyer, to make any press release or other public disclosure (including any filings with the SEC) with respect to such transactions
as is required by applicable law and regulations so long as the Company and its counsel consult with the Buyer in connection with
any such press release or other public disclosure at least one (1)&nbsp;Business Day prior to its release; provided, however, that
the Company&rsquo;s obligations pursuant to this Section&nbsp;11(i)&nbsp;shall not apply if the material provisions of such press
release, SEC filing, or other public disclosure previously has been publicly disclosed by the Company in accordance with this Section&nbsp;11(i).
The Buyer must be provided with a copy thereof at least one (1)&nbsp;Business Day prior to any release or use by the Company thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>.
This Agreement may be terminated only as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
the Buyer any time an Event of Default exists without any liability or payment to the Company. However, if pursuant to or within
the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding against the Company,
a Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes a general assignment
for the benefit of its creditors, (any of which would be an Event of Default as described in Sections 9(f), 9(g)&nbsp;and 9(h)&nbsp;hereof)
this Agreement shall automatically terminate without any liability or payment to the Company without further action or notice by
any Person. No such termination of this Agreement under this Section&nbsp;11(k)(i)&nbsp;shall affect the Company&rsquo;s or the
Buyer&rsquo;s obligations under this Agreement with respect to pending purchases and the Company and the Buyer shall complete their
respective obligations with respect to any pending purchases under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the Commencement shall not have occurred the Company shall have the option to terminate this Agreement for any reason
or for no reason without any liability whatsoever of either party to the other party under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that the Commencement shall not have occurred within ten (10)&nbsp;Business Days of the date of this Agreement, due
to the failure to satisfy any of the conditions set forth in Sections 6 and 7 above with respect to the Commencement, either party
shall have the option to terminate this Agreement at the close of business on such date or thereafter without liability of either
party to any other party; provided, however, that the right to terminate this Agreement under this Section&nbsp;11(k)(iii)&nbsp;shall
not be available to either party if such failure to satisfy any of the conditions set forth in Sections 6 and 7 is the result
of a breach of this Agreement by such party or the failure of any representation or warranty of such party included in this Agreement
to be true and correct in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
any time after the Commencement Date, the Company shall have the option to terminate this Agreement for any reason or for no reason
by delivering notice (a &ldquo;<B>Company Termination Notice</B>&rdquo;) to the Buyer electing to terminate this Agreement without
any liability whatsoever of either party to the other party under this Agreement. The Company Termination Notice shall not be effective
until one (1)&nbsp;Business Day after it has been received by the Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Agreement shall automatically terminate on the date that the Company sells and the Buyer purchases the full Available Amount as
provided herein, without any action or notice on the part of any party and without any liability whatsoever of any party to any
other party under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
by the Maturity Date for any reason or for no reason the full Available Amount under this Agreement has not been purchased as provided
for in Section&nbsp;1 of this Agreement, this Agreement shall automatically terminate on the Maturity Date, without any action
or notice on the part of any party and without any liability whatsoever of any party to any other party under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Except as set forth in Sections
11(k)(i)&nbsp;(in respect of an Event of Default under Sections 9(f), 9(g)&nbsp;and 9(h)), 11(k)(v)&nbsp;and 11(k)(vi), any termination
of this Agreement pursuant to this Section&nbsp;11(k)&nbsp;shall be effected by written notice from the Company to the Buyer, or
the Buyer to the Company, as the case may be, setting forth the basis for the termination hereof. The representations and warranties
of the Company and the Buyer contained in Sections 2, 3 and 5 hereof, the indemnification provisions set forth in Section&nbsp;8
hereof and the agreements and covenants set forth in Sections 4(e)&nbsp;and 11, shall survive the Commencement and any termination
of this Agreement. No termination of this Agreement shall affect the Company&rsquo;s or the Buyer&rsquo;s rights or obligations
(i)&nbsp;under the Registration Rights Agreement which shall survive any such termination in accordance with its terms or (ii)&nbsp;under
this Agreement with respect to pending purchases and the Company and the Buyer shall complete their respective obligations with
respect to any pending purchases under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Financial Advisor, Placement Agent, Broker or Finder</U>. The Company represents and warrants to the Buyer that it has not engaged
any financial advisor, placement agent, broker or finder in connection with the transactions contemplated hereby. The Buyer represents
and warrants to the Company that it has not engaged any financial advisor, placement agent, broker or finder in connection with
the transactions contemplated hereby. Each party shall be responsible for the payment of any fees or commissions, if any, of any
financial advisor, placement agent, broker or finder engaged by such party relating to or arising out of the transactions contemplated
hereby. Each party shall pay, and hold the other party harmless against, any liability, loss or expense (including, without limitation,
attorneys' fees and out of pocket expenses) arising in connection with any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules&nbsp;of strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Failure
or Indulgence Not Waiver</U>. No failure or delay in the exercise of any power, right or privilege hereunder shall operate as a
waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise
thereof or of any other right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>* * * * *</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 24; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Split-Segment; Name: 3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B> the Buyer and
the Company have caused this Common Stock Purchase Agreement to be duly executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><U>THE COMPANY</U>:</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">MARKER THERAPEUTICS,&nbsp;INC.</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">/s/ Peter Hoang</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Peter Hoang</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><U>BUYER</U>:</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">ASPIRE CAPITAL FUND, LLC</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">BY: ASPIRE CAPITAL PARTNERS, LLC</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">BY: SGM HOLDINGS CORP.</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Steven G. Martin</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Steven G. Martin</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> President</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT><B><U>Execution
Copy</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Schedule 3(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%">Subsidiaries</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Capitalization</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(e)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Conflicts</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(f)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">1934 Act Filings</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(g)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Material Changes</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(h)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Litigation</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(j)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Intellectual Property</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(l)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Schedule 3(p)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Transactions with Affiliates</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left">Exhibit&nbsp;A</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">Form&nbsp;of Officer&rsquo;s Certificate</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Exhibit&nbsp;B</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Form&nbsp;of Resolutions of Board of Directors of the Company</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Exhibit&nbsp;C</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Form&nbsp;of Secretary&rsquo;s Certificate</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DISCLOSURE SCHEDULES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(a)&nbsp;&ndash; Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marker Cell Therapy,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">GeneMax Pharmaceuticals,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">GeneMax Pharmaceuticals Canada,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(c)&nbsp;&ndash; Capitalization</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>(iv)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The Company is party to,
and has filed the resale registration statements required by, each of agreements detailed below. The Company has an ongoing obligation
to keep such resale registration statements continuously effective for the term specified in the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Securities Purchase Agreement, in the form
filed as Exhibit&nbsp;10.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K on June&nbsp;8, 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Registration Rights Agreement, in the form
filed as Exhibit&nbsp;2.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K on May&nbsp;15, 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>(vi)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The number of shares issuable
upon exercise of the Company&rsquo;s outstanding warrants are subject to customary adjustments in the event of certain stock split,
stock dividend, recapitalization and reclassification events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(e)&nbsp;&ndash; Conflicts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(f)&nbsp;&ndash; 1934 Act Filings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(g)&nbsp;&ndash; Material Changes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(h)&nbsp;&ndash; Litigation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 3(j)&nbsp;&ndash; Intellectual
Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Schedule
3(l)&nbsp;</B></FONT><B>&ndash; Title</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Schedule
3(p)&nbsp;</B></FONT><B>&ndash; Transactions with Affiliates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The
information under the heading &ldquo;Certain Relationships and Related Transactions&rdquo; in the Company&rsquo;s Definitive Proxy
Statement filed with the SEC on March&nbsp;28, 2019 is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF OFFICER&rsquo;S CERTIFICATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This Officer&rsquo;s
Certificate (&ldquo;<B>Certificate</B>&rdquo;) is being delivered pursuant to Section&nbsp;7(e)&nbsp;of that certain Common Stock
Purchase Agreement dated as of February&nbsp;28, 2020 (the &ldquo;<B>Common Stock Purchase Agreement</B>&rdquo;), by and between
<B>MARKER THERAPEUTICS,&nbsp;INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>ASPIRE CAPITAL FUND, LLC</B>,
an Illinois limited liability company (the &ldquo;<B>Buyer</B>&rdquo;). Terms used herein and not otherwise defined shall have
the meanings ascribed to them in the Common Stock Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">The undersigned, Anthony
Kim, Chief Financial Officer of the Company, hereby certifies as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
am the Chief Financial Officer of the Company and make the statements contained in this Certificate in my capacity as such;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
representations and warranties of the Company are true and correct in all material respects (except to the extent that any of such
representations and warranties is already qualified as to materiality in Section&nbsp;3 of the Common Stock Purchase Agreement,
in which case, such representations and warranties are true and correct without further qualification) as of the date when made
and as of the Commencement Date as though made at that time (except for representations and warranties that speak as of a specific
date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has performed, satisfied and complied in all material respects with covenants, agreements and conditions required by the
Transaction Documents to be performed, satisfied or complied with by the Company at or prior to the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy
Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate
involuntary bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to pay its debts as
they become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,&nbsp;I
have hereunder signed my name on this 28th day of February, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 35%">&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%">Name:</TD>
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 25%">Anthony Kim</TD>
    <TD STYLE="font-size: 10pt; width: 35%">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Title:</TD>
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"> Chief Financial Officer</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned as
Secretary of <B>MARKER THERAPEUTICS,&nbsp;INC.</B>, a Delaware corporation, hereby certifies that Anthony Kim is the duly elected,
appointed, qualified and acting Chief Financial Officer of <B>MARKER THERAPEUTICS,&nbsp;INC.</B> and that the signature appearing
above is his genuine signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">Michael Loiacono, Secretary</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 204.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 204.75pt"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 204.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>EXHIBIT&nbsp;B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF COMPANY RESOLUTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR SIGNING PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, management
has reviewed with the Board of Directors the background, terms and conditions of the transactions subject to the Common Stock Purchase
Agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) by and between the Company and Aspire Capital Fund, LLC (&ldquo;<B>Aspire</B>&rdquo;),
including all material terms and conditions of the transactions subject thereto, providing for the purchase by Aspire of up to
Thirty Million Dollars ($30,000,000) of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B>Common Stock</B>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
after careful consideration of the Purchase Agreement, the documents incident thereto and other factors deemed relevant by the
Board of Directors, the Board of Directors has determined that it is advisable and in the best interests of the Company to engage
in the transactions contemplated by the Purchase Agreement, including, but not limited to, the issuance of shares of Common Stock
to Aspire equal to $900,000 (3% of $30,000,000) as a commitment fee (the &ldquo;<B>Commitment Shares</B>&rdquo;) and the sale of
shares of Common Stock to Aspire up to the available amount under the Purchase Agreement (the &ldquo;<B>Purchase Shares,</B>&rdquo;</FONT>
<FONT STYLE="font-size: 10pt">a</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">nd together with the Commitment
Shares, the &ldquo;<B>Aspire Shares</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Transaction Documents</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, BE
IT RESOLVED, that the transactions described in the Purchase Agreement are hereby approved and the Chief Executive Officer and
Chief Financial Officer (the &ldquo;<B>Authorized Officers</B>&rdquo;) are severally authorized to execute and deliver the Purchase
Agreement, and any other agreements or documents contemplated thereby including, without limitation, a registration rights agreement
(the &ldquo;<B>Registration Rights Agreement</B>&rdquo;) providing for the registration of the shares of the Company&rsquo;s Common
Stock issuable in respect of the Purchase Agreement on behalf of Aspire, with such amendments, changes, additions and deletions
as the Authorized Officers may deem to be appropriate and approve on behalf of, the Company, such approval to be conclusively evidenced
by the signature of an Authorized Officer thereon; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the terms and provisions of the Registration Rights Agreement by and among the Company and Aspire are hereby approved and the Authorized
Officers are authorized to execute and deliver the Registration Rights Agreement (pursuant to the terms of the Purchase Agreement),
with such amendments, changes, additions and deletions as the Authorized Officer may deem appropriate and approve on behalf of,
the Company, such approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the terms and provisions of the Form&nbsp;of Transfer Agent Instructions (the &ldquo;<B>Instructions</B>&rdquo;) are hereby approved
and the Authorized Officers are authorized to execute and deliver the Instructions (pursuant to the terms of the Purchase Agreement),
with such amendments, changes, additions and deletions as the Authorized Officers may deem appropriate and approve on behalf of,
the Company, such approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Execution of Purchase Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the Company be and it hereby is authorized to execute the Purchase Agreement providing for the purchase of common stock of the
Company having an aggregate value of up to $30,000,000; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Issuance of Common Stock</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the Company is hereby authorized to issue the Commitment Shares to Aspire as Commitment Shares and that upon issuance of the Commitment
Shares pursuant to the Purchase Agreement, the Commitment Shares shall be duly authorized, validly issued, fully paid and non-assessable;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the Company is hereby authorized to issue shares of Common Stock upon the purchase of Purchase Shares up to the available amount
under the Purchase Agreement in accordance with the terms of the Purchase Agreement and that, upon issuance of the Purchase Shares
pursuant to the Purchase Agreement, the Purchase Shares will be duly authorized, validly issued, fully paid and non-assessable;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the officers of the Company be, and each of them hereby is, authorized and directed, for and on behalf of the Company, to execute
and deliver one or more stock certificates representing any Aspire Shares sold under the Purchase Agreement in such form as may
be approved by such officers, or to cause any such Aspire Shares to be delivered through electronic book entry; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Listing of Shares on the Nasdaq Global
Market</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the officers of the Company with the assistance of counsel be, and each of them hereby is, authorized and directed to take all
necessary steps and do all other things necessary and appropriate to effect the listing of the Aspire Shares on the Nasdaq Global
Market; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Approval of Actions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that,
without limiting the foregoing, the Authorized Officers are, and each of them hereby is, authorized and directed to proceed on
behalf of the Company and to take all such steps as deemed necessary or appropriate, with the advice and assistance of counsel,
to cause the Company to consummate the agreements referred to herein and to perform its obligations under such agreements; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FURTHER RESOLVED, that
the Authorized Officers be, and each of them hereby is, authorized, empowered and directed on behalf of and in the name of the
Company, to take or cause to be taken all such further actions and to execute and deliver or cause to be executed and delivered
all such further agreements, amendments, documents, certificates, reports, schedules, applications, notices, letters and undertakings
and to incur and pay all such fees and expenses as in their judgment shall be necessary, proper or desirable to carry into effect
the purpose and intent of any and all of the foregoing resolutions, and that all actions heretofore taken by any officer or director
of the Company in connection with the transactions contemplated by the agreements described herein are hereby approved, ratified
and confirmed in all respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF SECRETARY&rsquo;S CERTIFICATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Secretary&rsquo;s
Certificate (the &ldquo;<B>Certificate</B>&rdquo;) is being delivered pursuant to Section&nbsp;7(k)&nbsp;of that certain Common
Stock Purchase Agreement dated as of February&nbsp;28, 2020 (the &ldquo;<B>Common Stock Purchase Agreement</B>&rdquo;), by and
between <B>MARKER THERAPEUTICS,&nbsp;INC.</B>, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;) and <B>ASPIRE CAPITAL
FUND, LLC</B>, an Illinois limited liability company (the &ldquo;<B>Buyer</B>&rdquo;), pursuant to which the Company may sell to
the Buyer up to Thirty Million Dollars ($30,000,000) of the Company&rsquo;s Common Stock, par value $0.001 (the &ldquo;<B>Common
Stock</B>&rdquo;). Terms used herein and not otherwise defined shall have the meanings ascribed to them in the Common Stock Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned, Michael Loiacono Secretary
of the Company, hereby certifies as follows in his capacity as such:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
am the Secretary of the Company and make the statements contained in this Secretary&rsquo;s Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attached
hereto as Exhibit&nbsp;A and Exhibit&nbsp;B are true, correct and complete copies of the Company&rsquo;s bylaws (&ldquo;<B>Bylaws</B>&rdquo;)
and Certificate of Incorporation (&ldquo;<B>Certificate of Incorporation</B>&rdquo;), respectively, in each case, as amended through
the date hereof, and no action has been taken by the Company, its directors, officers or <FONT>stockholders</FONT>,
in contemplation of the filing of any further amendment relating to or affecting the Bylaws or Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Attached
hereto as Exhibit&nbsp;C are true, correct and complete copies of the resolutions duly adopted by the Board of Directors of the
Company on February&nbsp;18, 2020 at which a quorum was present and acting throughout. Such resolutions have not been amended,
modified or rescinded and remain in full force and effect and such resolutions are the only resolutions adopted by the Company&rsquo;s
Board of Directors, or any committee thereof, or the <FONT>stockholders</FONT> of the Company relating
to or affecting (i)&nbsp;the entering into and performance of the Common Stock Purchase Agreement, or the issuance, offering and
sale of the Purchase Shares and the Commitment Shares and (ii)&nbsp;and the performance of the Company of its obligation under
the Transaction Documents as contemplated therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the date hereof, the authorized, issued and reserved capital stock of the Company is as set forth on Exhibit&nbsp;A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>IN
WITNESS WHEREOF</B></FONT>,&nbsp;I have hereunder signed my name on this 28th day of February, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">Michael Loiacono, Secretary</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned, as Chief Financial Officer
of <B>MARKER THERAPEUTICS,&nbsp;INC.</B>, a Delaware corporation, hereby certifies that Michael Loiacono is the duly elected, appointed,
qualified and acting Secretary of <B>MARKER THERAPEUTICS,&nbsp;INC.</B>, and that the signature appearing above is his genuine
signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2011380d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<IMG SRC="tm2011380d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="background-color: white"><B>Marker
Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Houston, TX &ndash; March 2, 2020</B>&ndash;<U>&nbsp;Marker
Therapeutics, Inc.</U>&nbsp;(NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation
T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that
the Company has entered into a Common Stock Purchase Agreement (the &ldquo;Agreement&rdquo;) of up to $30 million with Aspire
Capital Fund, LLC (&ldquo;Aspire&rdquo;), a Chicago-based institutional investor and long-term Marker shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the Agreement, Aspire
has committed to purchase up to $30 million of the Company&rsquo;s common stock at Marker&rsquo;s discretion from time to time
during a 30-month period at prices based on the market price at the time of each sale. Marker will retain full control as to the
timing and amount of any sale of shares of common stock to Aspire, subject to certain limitations specified in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no warrants, options, financing
swaps, derivatives or other securities associated with this Agreement. Additionally, there are no financial covenants or restrictions
on future financings and there are no rights of first refusal, participation rights, penalties or liquidated damages. Lastly, Marker
maintains the right to terminate the Agreement at any time, at its discretion, without any additional cost or penalty. Proceeds
from the Agreement will be used to further advance the Company&rsquo;s pipeline including its post-transplant acute myeloid leukemia
(AML) Phase 2 trial, which is expected to begin in 2020, as well as for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;This Agreement with Aspire provides
Marker with the opportunity to access capital in an efficient manner,&rdquo; stated Peter L. Hoang, President and CEO of Marker.
 &ldquo;The financial flexibility provided by this transaction will further support the advancement of our clinical programs including
the first Marker-sponsored clinical trial this year investigating our novel MultiTAA cell therapy.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As consideration for Aspire&rsquo;s entering
into the Agreement, Marker issued 345,357 shares to Aspire as a commitment fee. Additional detail regarding the Agreement is set
forth in Marker&rsquo;s Current Report on Form 8-K, filed today with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release shall not constitute
an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or other jurisdiction.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Marker Therapeutics, Inc</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marker Therapeutics, Inc. is a
clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for
the treatment of hematological malignancies and solid tumor indications. Marker&rsquo;s cell therapy technology is based on
the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor
targets) and kill tumor cells expressing those targets. This population of T cells is designed to attack multiple tumor
targets following infusion into patients and to activate the patient&rsquo;s immune system to produce broad spectrum
anti-tumor activity. Because Marker does not genetically engineer its T cell therapies, we believe that our product
candidates will be easier and less expensive to manufacture, with reduced toxicities, compared to current engineered CAR-T
and TCR-based approaches, and may provide patients with meaningful clinical benefit. As a result, Marker believes its
portfolio of T cell therapies has a compelling product profile, as compared to current gene-modified CAR-T and TCR-based
therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To receive future press releases via email,
please visit:&nbsp;<B><U>https://www.markertherapeutics.com/email-alerts</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statement Disclaimer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B><I>This release
contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. Statements in this news release concerning the Company&rsquo;s expectations, plans, business outlook or future performance,
and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other
matters, are &ldquo;forward-looking statements.&rdquo; Forward-looking statements include statements regarding our intentions,
beliefs, projections, outlook, analyses or current expectations concerning, among other things: our use of proceeds from any sales
under the Agreement; our research, development and regulatory activities and expectations relating to our non-engineered multi-tumor
antigen specific T cell therapies; the effectiveness of the MultiTAA programs or the possible range of application and potential
curative effects and safety in the treatment of diseases; expectations regarding our supplier&rsquo;s delivery of the final reagent,
data and certificate of analysis required to advance the MultiTAA program for AML; and expectations regarding, among other things,
the timing, design and success of our clinical trials, including the AML trial, as well as clinical trials conducted by our collaborators.
Forward-looking statements are by their nature subject to risks, uncertainties and other factors which could cause actual results
to differ materially from those stated in such statements. Such risks, uncertainties and factors include, but are not limited
to the risks set forth in the Company&rsquo;s most recent Form 10-K, 10-Q and other SEC filings which are available through EDGAR
at www.sec.gov. The Company assumes no obligation to update our forward-looking statements whether as a result of new information,
future events or otherwise, after the date of this press release.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Solebury Trout</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chiara Russo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(617) 221-9197</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>crusso@soleburytrout.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Media</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Solebury Trout</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amy Bonanno</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(914) 450-0349</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>abonanno@soleburytrout.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2011380d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2011380d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K (X# 2(  A$! Q$!_\0
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M55&22< "OS9_;._X+MG0_%\OA+X):79^(;Q)_LC:[=1//!<2YV[;2%2#+EN
MY.UOX58$-7L/_!<#]H/4/@C^Q=/IND3/;7_CJ_30WF0X:*U,;R3X/^TJ",^T
MK>E<+_P0O_8IT/P/\"[3XLZM8Q7?BKQ4\PTV6:/)TRR20Q#8#T>1D9BXYV%
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M)WJ 2"TF1M;CEQ_P<.^._P#A&/[*_P"%9Z%_PEFS[,+G[9/Y/VG[N?LNW?\
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MQJ!D &MO]JCX>_MJ_MB_#F+PQXT^%>AS6%O=I?02VK6,5Q;RJ&7*/]J.,JS
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&ZI^6G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2011380d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2011380d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !? :D# 2(  A$! Q$!_\0
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M<W%2E*E;[,:RI2FM81DM3FPV-PN,E5CAJT:SH.U7E4K1:W5VDI6Z\KD?G/\
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M? ?_ -9G^#=?Z1E?YN?_  7K_P"4M7[6O^]\!_\ UF?X-U^U>!7_ "5N8_\
M9/8K_P!6.6GQ''G_ "*,-_V,:7_J-BC\@Z VUL'=M<&.0#_GG@RDC)V[F:%+
M8;HY0!=,2H7<P**_JX_)C^^W_@VU^,$WQ _X)WMX%O9]7OK_ .!7QG\=^ Q]
MNCLSI]GI7B*/1_B;I>F^&S:QPRSZ/IR>,KH".[M8+F.Y22&W>Y=5K]D/VJOB
MW:_ S]E_]H+XR3ZE=:0/A?\ !KXB^-HM4L;$:Q=Z;J'AWPIJM]I]W:V4L4T.
MH7%KJ4-K)'!-')%,RCST,+-G^1S_ (-9?BI)I'QT_:U^"-PLTUK\0?A?\-/B
MAIDDVNM#9Z1?_"KQ3XC\+:M;V/A]X=MWJGB[3_BQ8W6H:G:7=K/IUA\-],6Z
M@U2&^MFT;]EO^#A;XRM\+?\ @F1\4O#MM<ZYIVO?'7QS\*O@KH6I:'<6=OY-
MOJ7BJ/XD>-++7I+B\T^Z'A[Q3\,_AAX\\(:K8:1;ZQ<7CZ]96UW8+HTVL:EI
MW\9\89#.IXLXC)_8N2SS/<!5I4X\B558VIA,=-7O[.*6&I8VI*4[)NG*,E[6
M:A4_9\HQ_+PDL9S:X+ 5:$6[O]Y0HUXQCUE?F=)76BNG?EBVO\\MI[FX=Y[M
MC+=7!>6ZE(C1IKEV9I)I?*5(I[BXEEGNII((+"VCDG>.TL;>T>VLM.<O?_>/
MX],G\Z I&/;./Q(SZ^^.<X(I0,9]R3^=?V7",:<52C\%+#X2C2:32;IJTU:R
MMRJRU23^S<_&YU'.=:J_BQ$U.:[23;].KZ@>J?\ 76'_ -&I7^P O63Z+_,5
M_C_GJG_76'_T:E?[ "]9/HO\Q7\U>/\ _O?"O_7C,/\ U.P9^C\ ?[OG/I0_
M]-5"M=%/,C63:$9$=FWJ&*1%@YVM\P$1E1P\>3NPC[=R!_\ *$_:N^,*?M!_
MM/\ [0GQPAU6TU_3?BE\8_'_ (P\/ZY8Z5?:'9ZQX/U'Q%?)X(U2#2-3C@U+
M34OO!T.A73VFI6]MJ$<DC_;K:WNO.@C_ -,'_@H-\9[G]GG]B?\ :D^,VG:Y
MJ'AG7O _P*\?W7@_Q#I5I#>WVA^/-6T.Z\.^ =8CM[J"ZM633/&FL:!>S2W-
MM<VUK!#+=W-I=Q0&$_Y75K;I:6\%K%&(H[:**VBC4%!''"@5(]I>0IL50I3>
MRH055BBJ!?@#ESD^*\XY-)PI9'*>B]R<WB9V;U:25->ZK7>M]UGX@XB2I8+"
M0::E2>)JK9PIQ<(*3UUN^:R5WOI:Z+-=Y\*?B'>?"+XJ?#/XL:=J&IZ1??#'
MXA>"_'\.JZ+Y(UK3E\'^)-+\13W&C-.&C.JBVTZ?[!'(OD/=+ EZ38274,_!
MU!-&LJ2QN(V4Q/E)6,2'>%B8/.NUHHYXWDM9'60- LWVGRYEA:,_T;BJ$<7A
M,9A*GP8S!8S"5.ON8G#5:,]+._NS?1^CV/SRE)0JT:C=E2K4JM]=/95(SOIK
MIRIZ:G^OEH6J6>OZ)H^O:>DL5AK>DZ?JUE%<(L5Q':ZG:PWMND\2O(D4RPSH
M)(E=TB<%%<JN:^.O^"E7_*/']NG_ +-'_:#_ /56>*:XK_@E'\8;KXX?\$Y/
MV//B#J3ZY-JG_"EO#_@#7]4\3WRZAKOB'Q3\(;F]^#_B/Q9?WL;31W)\8:]X
M&U'Q1%*;B2=;;6+=)O-EWO7:_P#!2K_E'C^W3_V:/^T'_P"JL\4U_ %+#3P7
M$6%P=1)2P?$%+!W5O>CALPI4E*UW;F<&[/57LS][K5?;Y77KO_E]E%:HE_<G
MAY2B]$EKS/32VFB/\M9.W^Y%_P"@"GTQ.W^Y%_Z *?7^@O2'_7JA_P"F:9^
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MVM=]S\[II\BNM&Y.#[TW.IR2[JZ3T=FK:I'^H?\ \$PDS_P39_8./3;^R)\
M&&%:0DCX7>&SPD9\QSVVI\[$[5PQ%?Q-_P#!?3]J./\ :-_X*!^,?">@ZW%J
MG@#]F;1E^!GAQ+'4KB\TJ;Q;I>J3ZM\6M3C@BUG4=#CUR/QM>R>#/$=UIMAI
M-ZD'@/POH6L6=O/H5N^H?UE? C]I'1_V1_\ @A]^SQ^T1KD-G=6_PN_8)^"^
MNZ3IM]/#%#KWBZ?X8>%=)\%>'&2>^TL7,>N^*;_2M-G@MM3M]0DBN/*T^.XO
M)H8A_G*ZKK.N>)-7U7Q)XHUC4_$?BCQ'JNH>(O$_B/7+Z;4];\1>)=;N'O\
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M*Z.,JR,OS(P)5U^921S7SJ::36S2:]'J=Y)7^;G_ ,%Z_P#E+5^UK_O? ?\
M]9G^#=?Z1E?YN?\ P7K_ .4M7[6O^]\!_P#UF?X-U^U^!7_)6YC_ -D]BO\
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MTTUN?*RA.*BY1<8SNX-W]]1=FUHM$^S?Z"GJG_76'_T:E?[ "]9/HO\ 2O\
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MM7G\4?!'QBD%IH/A^RDF5+]]1\,?%WQ5KVM0P@W5O9>$+6Z\I[..[EB_J_\
M^"E7_*/']NG_ +-'_:#_ /56>*:_C[Q R]Y;XHUZ,:?LZ&(SK+,PHK9)8ZOA
M:TH+H^2<9IR3U;VC\*_7LEK_ %CA6[DI3H9=CL).5[N3PU.<%-K>/,G=1;;2
M7Q.]S_+63M_N1?\ H I],3M_N1?^@"GU_:"VA_UZH?\ IFD?C+_1?J?Z>7_!
M*JWA?_@FE^PM"RJJ2_LM?!XD#Y QN/!6GFXPJ@*N\S/C:!M#84**_@G_ ."O
M;,?^"G7[:RLS$)\:;DHI9BJ^9X0\(LX0%BH#$*Q 4<\C )!_H]_8<_X+S?L
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M_J-BC\@),F.15)4NC1E@<$"12C%3V8*Q*YXSC((S7['?M/\ PK-U_P $7?\
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MKC_GI'_Z,6O]?263:G_ W)Z\@%2WW06X#;_E 8[=H(S7^09W3_KI'_Z,6O\
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MW%])#>?VO?\ !2953_@G%^WJB@!5_8I_:=50 J@*OP/\<  *H55  & JA1T
M XK^=?%O,,XJ>(.29=BVXY/+%</YKE-)1C"+ABLURO"U)3:;E5FE[2'-*RC3
MG&,8WO*7Z'PIA<"LEQN,HPDL94P>-HXBHYSDG"-*I*$8P?NPW4GRZMV;>D;?
MY;@'.3[CWQD_TQC\:6BBOZIK:UJ\NLJ^(;_[<Q%:C&RV5J="DK+2\6]Y,_+(
M)1ITXK:,%%==%*I;5ZO=ZL: 2>/1CCG(2,!G<N5$**J$MMGEA:5DV0"5V1&;
MC@\YQ^G'4'.<C'MGT YK]L/V4_\ @E[?_&W_ ()8?MF?MI7VE7ESXU\,_8)_
MV>K;[#J-R)/#'P5\46'B3X[:S8V4#HFJMXGTVVUGP58ZC*MU9:%J&@Z[<;5:
M":*'\3U92H88VL RMP<C PPQUR#D?7()!X\7*L\RS-\1G&&P=6=>MD.*A@<P
M<FW#ZQ52J4W33;7)2DG2DTHISIU(V?*V^K$8?$970P%6O1:CCJ-:LYWO>#FU
M3DDU[ON36BWYDV?O7_P;I?M+)\#OV_X?A?K=ZMMX/_:E\#7GPSGCF>Q@@@^(
MOA2>X\;_  RU1IY=/N;^:>9;7QAX(L]+M+NTMKN]\=V^IWKA]!M!)_H'0G,>
M>IP<GG!;?\Q ).%+9*+DA5PJDJ :_P CKX;_ !#\4_"/XB> OBMX(GD@\8?#
M3Q?X=\?>'0EWJ%D+G5?"6N:9K]A87%WIDUO>QZ=J-Y8VVFZPD$R/<:5?7@82
MQ121/_K%?"?XE>%OC/\ "[X=?%_P/<S7G@WXI^!?"GQ$\+7-S$;>ZET#QGHE
MAXATHW=LQ+VMXMGJ$4=Y:.1):72S6TBH\3*/YG\?LC>&XBRG/Z=-0I9S2PL*
M\HQ2C/&8>I-.6B2@Y8?E?*M).#:UBS]0X"QJJ8/$9<W?ZAB/W"?Q1P]6FY<L
MGO*U6_O/6TK;6/\ .P_X+P?\I<OVQ?\ K_\ @)_ZRG\"J_)2OUK_ ."\'_*7
M+]L7_K_^ G_K*?P*K\E*_HK@W_DD.%?^R;R3_P!0$?G.>?\ ([S?_L/K?E ]
M_P#V?OV4OVC_ -JW4_%6C?LX?![Q=\8=4\$6>E:AXNL?":Z4LN@V6O3WEKHU
MQ>2:SJ.E6[+?SZ?>I&()YFC6VDDD" %5^FG_ ."0'_!3_P M\_L2_&4_(X _
MXHAB24../^$P7O@'YCQD@-T/[-_\&J:K_P +A_;68[AN^&7P,4N6. %\6?%$
M@("VQ22YW$*"Q5<L<8']I#QB10""P!! /*OTP2,X.,9'7E<CU'Y!QSXN9YPQ
MQ3CLFR_*<LE2P4<'.GB)RKRK\TZ-&K/$3M5C&4G*HY>R2<(I*-KZ/ZS).$L#
MFV683'5,?F-&56=>%2FN3V,I4YRA&"4H-QI)QLFFN:.[LS\^_P#@E/\ #'X@
M_!?_ ()\_LN_"KXK^$]3\#?$3P5\.Y=*\6>$-9-JVJ:'J,GBGQ)=QVMXUE/<
MVID>UGM[@""XE01S)DY.*_GO_P"#L $>(_\ @GJ#C_D$?M@XQZ?;_P!DVO[%
MHU"OU)8]03D<^G' '\(' '0<DU_'3_P=@'/B+_@GH?\ J$?M@_\ I?\ LG=^
M]?G'A3BJN.\5LEQU6+A/&YEF>+E%MV]I7RS-ZE24>9\RCS3:2>RM?5GU/$-&
M&'X8Q^'ISYX8?!QHJ5]^1THJZ6E[1^6O>R_D3[#/]T>_9NQZT'(+=!D# /<]
M%48!8LS%44!3EG4$;>:4<X^B_P FK] _^"5'PO\ A[\;/^"B/[*WPH^*_A#2
M/'OPY\;^,O%FF^+/!^O0R7&CZY8V7PI\?:W:0WT4<MNS16>JZ98:DF)D(N+*
M!E#LJH?ZWQN,HY9D^*S.K&4E@,BQF-2B[-SP> E7HK5J+M-OW9M0E=*;2U/Q
M_!X:.*S# X>2O]9G2H)-OEN\/%Q>E[6E9MV;M=6/S[VY[C.<D#.,'!&,X(#+
MAUR Q1EZ9Y1V$*/(Q<)&K2$QJ'E544LQB1OE:08RBM\K, &.#7Z2_P#!6_\
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MK;VJ!%"(D4,>4  #/(=S$Y;\QE;FER_#S/E]+NWX'TBO97WLK^O4V*_S<_\
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M-O%TR^C\,?#PS_$?Q;?6M])\D3Z3X;\*ZCJ<J*'EEAMG@CBDDD$9_3WF\?\
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M4G;EYK)J+DDF];N+:=OY[2 >H!Y!P1D9 (!P>X#, >H#,!]XY_OT_P"#</\
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M*/B(WAN70O'MKIVH_#WQ/:ZTUKI%_P"'?%>KVFKWD&F7>H-)^F?[*/QV\/\
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MCJ,E3PL)PIXJ,7S8;_E]3C>[52R=Y.^DOAWLY)QD_P!=K>1&1@JDC>5X.\8
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>P5,;C'9Y?4CF%&VM9NGH]++FO34KK5VC==7JC__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
